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ABSTRACT 
Lipopolysaccharide (LPS), a glycolipid found in the outer membrane of Gram negative 
bacteria, induces the secretion of pro-inflammatory cytokines such as tumor necrosis 
factor alpha (TNF-a) and interleukin (IL )-1, by monocytes/macrophages. Excessive and 
uncontrolled secretion of these compounds leads to multiple pathological conditions, 
such as septic shock. LPS receptors have been shown to be CD14, TLR4 and MD-2. LPS 
interaction with these receptors mediates many monocyte/macrophage functions. Even 
though only CD14 was demonstrated to bind to LPS, and TLR4/MD-2 were capable of 
transducing signals, data only show that LPS and CD 14 were in close proximity to TLR4 
and no direct binding was reported. Quite recently, moesin, a member of the ERM 
family of proteins, has been also found to function as a receptor for LPS. We have 
shown that anti-moesin antibody inhibited the release of TNFa by LPS stimulated 
monocytes. Moesin was also found to be necessary for the detection of LPS, where 
homozygous knockout mice exhibited 3-fold reduction in neutrophil infiltrates in LPS 
injected sites when compared to their wild type controls. When moesin gene expression 
was completely suppressed with antisense oligonucleotides, there was a significant 
reduction of LPS-induced TNF-a secretion. LPS stimulation of mononuclear phagocytes 
activates several intracellular signaling pathways including the phosphorylation of IKBa, 
mitogen-activated protein kinase (MAPK) pathways: extracellular signal-regulated 
kinases (ERK) 1 / 2 (P44/42), p38. These signaling pathways in tum activate a variety of 
transcription factors including NF-KB, which coordinates the induction of several genes 
encoding inflammatory mediators. Thus, moesin would serve as a mediator and/or 
V 
signaling molecule in LPS-induced macrophage response. The aim of this study was to 
characterize and investigate moesin mediated intracellular signaling in LPS-stimulated 
mononuclear phagocytes. The results showed that moesin is expressed on the surface of 
macrophage like differentiated THP-1 cell. The surface expression is increased after LPS 
stimulation. Total protein mass of moesin is increased LPS stimulation. When studying 
the active (phosphorylated) form of moesin, we found moesin to be activated upon LPS 
stimulation. lmmunoprecipitation experiments showed that moesin co-precipitates with 
CD14, TLR4 and MD-2. the co-immunoprecipitation of moesin with CD14 was LPS 
independent while it was LPS dependant in TLR4 and MD-2, suggesting an early role of 
moesin in the formation of the LPS receptor complex. When cells were pre-incubated 
with anti-moesin antibody, there was inhibition of NFKB and p38 and p44/42 MAPK 
activity. These findings further confirm the role of moesin in LPS mediated intracellular 
cascade. 
In conclusion, the activation of moesin in macrophages is highly dynamic and appears to 
be regulated positively by LPS. It is our view that based on the lack of compelling 
binding data; TLR4 might well be downstream of the initial step of LPS recognition. 
LPS binds first to moesin and CD14 and TLR4 is recruited later. Therefore, we propose 
a model were the innate recognition of LPS involves the dynamic association of multiple 
receptors forming a cluster of molecules. 
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INTRODUCTION 
Lipopolysaccharide (LPS) is the principal component of the outer membrane of Gram-
negative bacteria. Mononuclear phagocytes orchestrate the innate immune response to 
LPS, a potent activator of mononuclear phagocytes , by expressing a variety of 
inflammatory cytokines that include tumor necrosis factor-alpha (TNF a) and interleukin-
1 ~ (IL-1~) (Beutler et al., 1986; Nathan, 1987; Raetz, 1990). Production of these 
inflammatory cytokines by mononuclear phagocytes contributes to the efficient control of 
growth and dissemination of invading pathogens. However, excessive and uncontrolled 
production of these inflammatory cytokines may lead to serious systemic complications 
such as microcirculatory dysfunction, disseminated intravascular coagulation, multiple 
organ failure and septic shock (Morrison and Ryan, 1987; Tracey et al., 1986; Tracey et 
al., 1987; Ulevitch and Tobias, 1995). Despite intensive research there is no cure for 
LPS-related complications and it is estimated that 175,000 people die each year in the 
United States of septic shock or systemic inflammatory syndrome (Parrillo et al., 1989; 
Parrillo, 1993). Thus, studies on the molecular basis of LPS recognition by macrophages 
and the regulation of inflammatory genes may identify novel therapeutic approaches. 
Studies on the molecular mechanisms of LPS-induced macrophage activation and 
desensitization have suggested the involvement of various kinases such as protein kinase 
A (Muroi and Suzuki, 1993), protein kinase C (Fujihara et al., 1994) and the 3 classes of 
mitogen-activated protein kinases (MAPK): extracellular signal-regulated kinase (ERK) 1 
1 
and ERK2(Weinstein et al., 1992), p38 MAPK (Han et al., 1994a), and c-Jun N-terminal 
kinases (JNK)(Hambleton et al., 1996). Numerous inflammatoiy cytokines as well as 
mediators are expressed in LPS-stimulated macrophages through transcription factors 
including nuclear factor KB (NF-KB) and activator protein-I (AP-l)(Fujihara et al., 1993; 
Guha and Mackman, 2001; Muroi et al., 1993). It is currently believed that LPS binding 
protein (LBP), a serum glycoprotein, first binds to the lipid A moiety of LPS (Gegner et 
al., 1995; Guha and Mackman, 2001; Thompson et al., 2003). LPS-LBP complex is then 
recognized by CD14, another LPS binding molecule (Haziot et al., 1996; Schumann et 
al., 1990; Ulevitch and Tobias, 1995). CD14 is a glycoprotein, which is expressed on 
myelomonocytic cells as a glycosylphosphatidylinositol-anchored (GPI-anchored) 
molecule. Mice with a targeted deletion of the gene encoding CD 14 are hyporesponsive 
to LPS and resistant to the lethal effects of LPS (Haziot et al., 1996). However, mice 
lacking CD 14 are still able to respond to high concentrations of LPS and in vitro deletion 
of LBP gene in mice seemed to have no effect on LPS sensitivity in vivo (Wurfel et al., 
1997). Moreover, CD 14 does not have a cytoplasmic signaling domain making it 
incapable of downstream signaling (Haziot et al., 1988; Van Amersfoort et al., 2003). 
These findings suggest a strong role for LBP and CD 14 only in amplifying LPS response 
and/or function to bring LPS to another signal transducer. Thus the ability of the host to 
recognize LPS is not composed of one single molecule and triggering of intracellular 
signals is probably mediated by an additional receptor (s). 
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Members of a family of proteins, the mammalian homologues of the Drosophila Toll 
protein, Toll-like receptor (TLR) proteins were identified and found to respond to LPS, 
thereby modulating the innate immune response (Medzhitov et al., 1998). The TLR 
proteins possess leucine-rich extracellular repeats which recognize the LBP-CD14 
complex (Poltorak et al., 2000). Interestingly, the TLR intracellular domain resembles the 
IL-1 ~ receptor, hence the term TolVIL-1 receptor homology domain (TIR) (Chaudhary et 
al., 1998; Medzhitov et al., 1997; Rock et al., 1998) and TLRs utilize IL-I~ signaling 
components including adaptor protein MyD88, interleukin- I receptor-associated kinase 
(IRAK), and TNF receptor-activated factor 6 (TRAF6) (Jiang et al., 2000). After TLR4 
activation, MyD88 is recruited to TLR4 through respective TIR-TIR interactions 
(Medzhitov et al., 1998; Muzio et al., 1998; Raschi et al., 2003). MyD88 also contains a 
death domain (DD), a highly conserved protein-binding domain that facilitates its 
interaction with another DD-containing signaling molecule, interleukin- I receptor-
associated kinase (IRAK) (Daun and Fenton, 2000; Jiang et al., 2000). IRAK 
subsequently autophosphorylates, dissociates from MyD88, and interacts with TNF 
receptor-associated factor-6 (TRAF6) (Aderem and Ulevitch, 2000; Cao et al., 1996; 
Jiang et al., 2000; Raschi et al., 2003; Swantek et al., 2000; Yamin and Miller, 1997). 
This activates a downstream kinase cascade involving NF-KB-inducing kinase and IKB 
kinase, resulting in the phosphorylation and degradation of the NF-KB inhibitor, IKB, and 
the nuclear translocation of NF-KB (Daun and Fenton, 2000). Nevertheless, there is 
significant controversy as to whether or not LPS actually interacts directly with TLR. 
Attempts to identify LPS binding ability to TLR showed that LPS did bind to TLR2 but 
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the kinetics associations was slow (Yang et al., 1998) suggesting that this was a low 
affinity interaction. In another experiment(da Silva Correia et al., 2001), using 1251-
labeled LPS probe, it was demonstrated that TLR2 and TLR4 were labeled in the 
presence of CD 14, however , crosslinking modifiers implied that only the photoaffinity 
crosslinking probe and the molecule were in sufficient close proximity to permit covalent 
interaction. Moreover, when studying the association of TLR4 to CD 14, Jiang et al. 
(Jiang et al., 2000) showed that LPS stimulation promoted physical proximity between 
CD 14 and TLR4 suggestion a close interaction but not binding. 
Quite recently, using cross-linking assay, moesm, a member of the ERM family of 
proteins , has been also found to function as a receptor for LPS. It was shown that anti-
moesin antibody inhibited the release of TNFa by LPS stimulated monocytes (Tohme et 
al., 1999). Moesin was also found to be necessary for the detection of LPS, where 
homozygous knockout mice exhibited 3-fold reduction in neutrophil infiltrates in LPS 
injected sites when compared to their wild type controls (Amar et al., 2001). The ERM 
family of proteins comprises three structurally related proteins, ezrin, radixin and moesin 
(Bretscher et al., 2002; Lankes et al., 1993; Sato et al., 1992; Tsukita and Yonemura, 
1999). These proteins exhibit ~85% amino terminal identity with talin and merlin, and all 
together belong to the band 4.1 superfamily (Lankes and Furthmayr, 1991). ERM 
proteins are often co-expressed in various tissues and cells where they are localized in 
filopodia, microvilli, microspikes, retraction fibers, membrane ruffles, and adhesion 
contacts. Such microextensions and membrane formations are considered important for 
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cell-cell and cell-substrate recognition, for signal transduction and for motility (Amieva 
and Furthmayr, 1995). Moesin binds F-actin and functions as a membrane-cytoskeleton 
linking protein together with radixin and ezrin (Henry et al., 1995; Turunen et al., 1994). 
Moesin is widely expressed in macrophages, lymphocytes, fibroblasts, epithelial cells, 
neuronal cells and certain types of tumor cells. In areas of inflammation, Masumoto et 
al. (Masumoto et al., 1998) has shown moesin to be highly expressed in both the center 
and periphery of neutrophils. Moesin has been reported to have diverse biological 
functional activities, ranging from a structural protein to a receptor (Ariel et al., 2001; 
Batchelor et al., 2004; Faure et al., 2004; Helander et al., 1996; Sagara et al., 1995; 
Takahashi et al., 1998; Tsukita et al., 1994; Yonemura et al., 1998). 
As mentioned earlier, LPS stimulation of mononuclear phagocytes activates several 
intracellular signaling pathways including the phosphorylation of IKBa, mitogen-
activated protein kinase (MAPK) pathways: extracellular signal-regulated kinases (ERK) 
1 / 2 (P44/42), p38. These signaling pathways in tum activate a variety of transcription 
factors including NF-KB, which coordinates the induction of several genes encoding 
inflammatory mediators. Thus, moesin would serve as a mediator and/or signaling 
molecule in LPS-induced macrophage response. The aim of this study is to characterize 
moesin mediated intracellular signaling in LPS-stimulated mononuclear phagocytes. 
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LITERATURE REVIEW 
LIPOPOLYSACCHARIDE (LPS): 
Structure: 
LPS is the main building block of the outer leaflets of bacterial cell wall, membranes, as 
such contribute to, and is essential for stability and growth. Often outer layers of 
bacterial cell walls are not directly exposed to the external environment because many 
naturally occurring gram-negative bacteria are fitted with this thick polysaccharide 
capsule (Roberts, 1996). 
As a major constituent of the outer membrane of all gram-negative bacteria, LPS is the 
only lipid constituent of the outer leaflet; a single E. coli cell contains approximately 3 .5 
x 106 LPS molecules (Raetz and Whitfield, 2002; Rietschel et al., 1994). Other 
components of the bacterial outer membrane are glycerophospholipids in the inner leaflet 
and inner membrane and proteins ( e.g., pore proteins such as OmpA in E. coli), some of 
which are firmly associated with LPS molecules (Lugtenberg and Van Alphen, 1983; 
Raetz and Whitfield, 2002). LPS is a prerequisite for bacterial viability; is not toxic 
when it is incorporated into the bacterial outer membrane, but after release from the 
bacterial wall, its toxic moiety, lipid A, is exposed to immune cells, thus evoking an 
inflammatory response. LPS and other cell wall constituents are released from the 
bacterial cells not only while they multiply, but also when bacteria die or are lysed 
(Hellman et al., 2000; Rietschel et al., 1994). Various endogenous factors like 
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complement and bactericidal proteins can cause disintegration of bacteria, resulting in the 
release ofLPS (Smedsrod et al., 1994). 
The LPS molecule consists of four different parts (Lugtenberg and Van Alphen, 1983; 
Raetz, 1990; Raetz and Whitfield, 2002; Rietschel et al., 1994). The first and most 
essential part is lipid A, the covalently linked lipid component of LPS. Six or more fatty 
acid residues are linked to two phosphorylated glucosamine sugars. Four of these fatty 
acids carry a hydroxyl group on the third carbon, whereas the other two are not 
hydroxylated (Raetz and Whitfield, 2002). All bacterial species carry unique LPS forms. 
Some of the variations in LPS structure reside in the lipid A moiety: (i) Acylation pattern, 
which can be at an asymmetric (4 + 2), or a symmetric (3 + 3) configuration (e.g., in 
Neisseria meningitidis ); (ii) Length of the fatty acid residues; typically three or four 
different fatty acids are present, with a length between 10 and 16 C atoms ( average, 14 C 
atoms). (iii) the presence of 4-amino-deoxy-L-arabinose and/or phosphoethanolamine 
linked to the phosphate groups on the glucosamine sugars. (iv) Number of fatty acids 
(most common bacteria contain six fatty acid residues) (Lugtenberg and Van Alphen, 
· 1983; Raetz, 1990; Raetz and Whitfield, 2002; Rietschel et al., 1994). Experiments with 
synthetic lipid A have shown that this part of the LPS molecule represents the toxic 
moiety (Kotani et al., 1985). A number of synthetic derivatives of lipid A 
( dephosphorylated or deacylated) have been tested in vivo and in vitro, and the potency of 
these molecules were 10- to 1,000-fold reduced with respect to the original lipid A 
molecule (Dziarski, 1991; Loppnow et al., 1989; Muller-Loennies et al., 1998). In 
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addition, the lipid A precursor , lipid IV A, dose dependently inhibited the effects of lipid 
A, as shown by reduced TNF-a and prostaglandin E2 (PGE2) production in vitro. 
Another lipid A precursor , lipid X, has limited lipid A antagonist activity (Golenbock et 
al., 1993). This illustrates that lipid A-induced cell activation requires a more strict 
structure than lipid A binding to the receptor per se. 
The second part of the LPS molecule is the inner core, which consists of two or more 2-
keto-3-deoxyoctonic acid (KDO) sugars linked to the lipid A with glucosamine and two 
or three heptose (L-glyceroD-mannos-heptose) sugars linked to the KDO. Both sugars 
are unique to bacteria (Van Amersfoort et al., 2003). The smallest LPS molecule 
produced by gram-negative bacteria under natural conditions is Re-LPS (lipid A with one 
or two KDO sugars), but longer LPS molecules are more common. The Rd 1- and Rd2-
LPS serotypes contain a complete inner core and an inner core lacking two heptose 
sugars, respectively. The outer core, the third part of the LPS molecule, consists of 
common sugars and is more variable than the inner core (Van Amersfoort et al., 2003). It 
is normally three sugars long with one or more covalently bound sugars as side chains. 
LPS serotypes consisting of lipid A and the complete inner and outer core are denoted 
Ra-LPS, whereas the Rb- and Rc-LPS serotypes only contain a part of the outer core. 
The fourth moiety of the LPS molecule is the O antigen. This part of the LPS molecule is 
attached to the terminal sugar of the outer core, extends from the bacterial surface, and is 
highly immunogenic. It is composed of units of common sugars, but there is a huge 
interspecies and interstrain variation in the composition and length. In a single LPS 
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preparation , the length of the O antigen may vary from O to as many as 40 repeating 
units, but it generally consists of 20 to 40 repeating units. Each unit is composed of three 
sugars with a single sugar connected to the first and third sugar of the unit. LPS 
molecules with O antigen are denoted S-LPS. Colonies from bacteria with O antigen-
containing LPS have a smooth (S) appearance on the plate , while bacteria that express an 
O-antigen-lacking LPS have a rough (R) appearance. 
LPS-mediated inflammatory responses: 
The release of the cytokine TNF-a is important in the development of immune responses 
to an infection. The production and release of certain cytokines, induced by LPS, appears 
to be under posttranscriptional control. TNF-a is strongly and specifically induced by a 
threefold increment in transcriptional activity but a 100-fold increase in the cellular 
mRNA content (Beutler et al., 1986). The role of gene expression in increasing TNF-a 
levels has been studied and it has been shown that both nuclear and cytoplasmic 
mechanisms contribute to the regulation of this process (Wilson and Treisman, 1988). 
The downstream sequence present in the TNF-a mRNA is sufficient to mediate a = 
200-fold induction of chloramphenicol acetyltransferase synthesis in response to 
activation by LPS. It has been shown that TNF-a receptors are down regulated in 
response to LPS, which may act as a protective mechanism against overproduction of 
TNF-a in the host (Ding et al., 1989). TNF-a directly stimulates endothelial and 
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mononuclear cell biosynthesis and release of IL-1. The release of IL-6 occurs following 
stimulation with LPS and TNF/IL-1 and is cAMP dependent (Gauldie et al., 1987). 
The Role of LPS in Disease: 
Septic shock causes approximately 175,000 deaths annually in the USA (Parrillo et al., 
1989; Parrillo, 1993) where gram-negative bacteria may account for up to one half of 
these cases. Septic shock is characterized by refractory hypotension leading to 
inadequate organ perfusion, multi-organ failure, and frequently death. The endotoxin 
(LPS) of gram-negative bacteria is believed to be responsible for the initiating host 
responses leading to septic shock (Wong et al., 2003; Zhao et al., 2002). LPS is not 
intrinsically toxic but leads to toxicity by inducing myeloid and/or nonmyeloid cells to 
express a multiplicity of genes encoding proteins with activities that produce the 
hematologic changes observed in septic shock (Andreakos et al., 2004). 
Immune cells in essentially all multicellular organisms recogmze LPS. After the 
recognition, two types of responses that combat bacterial infections are elicited. First, 
phagocytic cells engulf and kill the bacteria, and cells in the liver and spleen pinocytose 
fragments of shed membrane. These activities physically dispose of the infection threat. 
In the second response, leukocytes, as well as other cells, respond to LPS by secreting a 
variety of cytokines that heighten the defensive responses of the host (Burke and Lewis, 
2002). For example, TNF-a, IL-1-~, and IL-6 are secreted significantly following the 
stimulation of mononuclear phagocytes with LPS (Aird, 2003a; Aird, 2003b ). These 
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substances induce the acute-phase response and may further prime the immune system 
for rapid action. Although the secretory responses to LPS are usually beneficial, 
exaggerated responses may be fatal. In response to endotoxic shock, patients and 
experimental animals first exhibit a neutropenia , followed by fever, induction of the acute 
phase response, disseminated intravascular coagulation, multiple organ failure , and a 
catastrophic fall in blood pressure (Aird, 2003a; Aird, 2003b ). Studies have suggested 
TNF-a as a principal mediator of these complications (Joshi et al., 2003; Thijs et al., 
1993; van der Poll and Lowry, 1995). Indeed, infusion of TNF-a mimics many of the 
effects of LPS in animals (Tracey et al., 1986) and the reduction of TNF levels with 
anti-TNF antibody prevents many of the physiological responses to LPS (Joshi et al., 
2003; Mathison et al., 1988). 
In the oral cavity, inflammation of the supporting tissues of the teeth produces 
periodontitis, one of the most common groups of human disease. Depending on the 
extent of the inflammation , the destructive process may involve the gingiva and/or the 
periodontal ligament and alveolar bone surrounding and supporting the teeth (Page and 
Kornman, 1997; Page et al., 1997). The mechanisms associated with these common oral 
inflammatory diseases are poorly understood. Periodontitis may involve both the direct 
cytotoxic and proteolytic effects of the dental plaque and the indirect pathologic 
consequence of the host's immune response to the continued presence of bacterial plaque 
microorganisms (Listgarten, 1987). Indeed, interaction of bacterial products and antigens, 
including those from several putative periodontal pathogens, with inflammatory cells 
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results in the release of cytokines such as IL-1 and TNF-a. These factors are known to 
stimulate bone resorption and secretion of proteinases and may be involved in attachment 
loss and bone resorption, which are characteristic features of periodontitis (Dennison and 
Van Dyke, 1997; Reynolds and Meikle, 1997). IL-1 is produced predominantly by 
macrophages activated by microbial substances, immune complexes or other cytokines. 
As low as 1 ng/ml LPS can activate the production, and release of IL-1 which can be as 
high as 100 ng per 106 cells/24 hours (Lindemann and Economou, 1988). IL-1 
production can also be activated by TNF-a or IL-1 can induce its own production in an 
autostimulatory fashion; via its capacity to amplify and perpetuate the inflammatory 
response and tissue destruction. 
In chronic periodontitis, IL-1 ~ and TNF-a have been detected in inflamed gingiva and 
shown to be important mediators of the inflammatory process (Stashenko et al., 1991 ). 
The local generation of IL-1 ~ and TNF-a by macrophages in the gingiva after bacterial 
infection can act in classical paracrine fashion to induce the expression of IL-8 by 
nonimmune cells ( e.g. endothelial cell surrounding the macrophages). IL-8 derived from 
cells in the gingiva, including gingival fibroblasts, can cause neutrophils to accumulate 
and to be active in inflamed gingival (Lo et al., 1999; Miyauchi et al., 2001). Thus, the 
capacity of human gingival fibroblasts to produce IL-8 in response to IL-1 ~ and TNF-a 
suggests that the fibroblasts and other immune cells play a critical role in the tissue 
microenvironment (Lo et al., 1999; Miyauchi et al., 2001; Takashiba et al., 1992). 
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MACROPHAGES 
Macrophages are the major differentiated cells of the mononuclear phagocyte system. 
This system comprises bone marrow monoblasts and promonocytes, peripheral blood 
monocytes, and tissue macrophages (Burke and Lewis, 2002). Macrophages are widely 
distributed throughout the body, displaying great structural and functional heterogeneity. 
They are to be found in liver, lungs, lymphoid organs, gastrointestinal tract, central 
nervous system, serous cavities, bone, synovium, and skin (Burke and Lewis, 2002). 
These cells participate in a wide array of physiological and pathological processes. 
The term "macrophage" was first used more than a decade ago by Elie Metchnikoff to 
describe the large mononuclear phagocytic cells he observed in tissues (Kamovsky, 
1981 ). These cells were originally grouped in the reticuloendothelial system (RES), a 
broad system of cells which included reticular cells, endothelial cells, fibroblasts, 
histiocytes and monocytes (Aschoff, 1924). However, since the RES included cells of 
non-macrophage lineage, it did not represent a true system and the term was replaced 
with the current title "mononuclear phagocyte system" (MPS), on the basis that 
macrophages shared important functional characteristics in vivo and were derived from 
monocytes (van Furth et al., 1972), whereas endothelial cells and fibroblasts were not. 
Phylogenetically, the mononuclear phagocyte is a very primitive cell type, with related 
cells being found in early life forms, and some single-cell protozoa exhibiting features 
similar to the mammalian macrophage (Burke and Lewis, 2002). Ontogenetically, the 
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macrophage originates in the yolk sac (Moore and Metcalf , 1970), but arises from the 
bone marrow in adult human (van Furth, 1989). 
Origin and Kinetics of Macrophage: 
Macrophages originate m the bone marrow. In humans , the bone marrow contains 
resident macrophages, as well as their precursors: monocytes, promonocytes and 
monoblasts. There is sufficient data to suggest that monocytes and neutrophils share a 
common progenitor cell in the bone marrow (Metcalf , 1971 ). This common progenitor is 
called the granulocyte-macrophage colony-forming unit , (GM-CFU) because of its ability 
to give rise to colonies of monocytes and neutrophils in semi-solid marrow cultures. It is 
likely that at a level of maturity preceding the promonocyte and promyelocyte stage, a 
progenitor cell becomes committed to either monocytic or granulocytic differentiation. 
However, the human promyelocytic leukemia cell line HL-60 differentiates to monocytes 
and macrophages in the presence of certain phorbol esters but to neutrophils in the 
presence of dimethylsulfoxide, suggesting that cells may switch at a later point (Koeffler 
and Golde, 1980). 
The monoblast is the least mature cell of the mononuclear phagocyte system. This 
immaturity is reflected in the morphology and ultrastructure (van Furth et al., 1980). The -
monoblast is positive for lysozyme and non-specific esterase , although these enzymes are 
only present in relatively small amounts. All monoblasts have receptors for lgG and are 
able to phagocytose IgG-coated red blood cells, but not C3b-coated red blood cells and 
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only rarely ingest opsonized bacteria (van Furth et al., 1980). Division of a monoblast 
gives rise to two promonocytes, the latter cell type being the direct precursor of the 
monocyte. Promonocytes stain positive for lysozyme and non-specific esterase, and in 
addition have peroxidase-positive granules. The majority of promonocytes have IgG Fe 
receptors and C3b receptors, and ingest IgG-coated red blood cells and opsonized 
bacteria, but relatively present on few C3b-coated red cells (van Furth and Diesselhoff-
Den Dulk, 1970; van Furth et al., 1980). Unlike monoblasts, they appear to pinocytose 
greatly. It is believed that each dividing promonocyte gives rise to two monocytes. The 
cycle of monoblastic and promonocytic division in mice has been calculated to be 11.9 
and 16.2 hours, respectively. Newly formed monocytes probably remain in the bone 
marrow for less · than 24 hours before entering the peripheral blood, where they are 
distributed between circulating and marginating pools (Meuret and Hoffmann, 1973; van 
Furth and Sluiter, 1986). Research in mice have shown that monocytes have a half time 
in the circulation of 17.4 hours under normal circumstances (van Furth and Cohn, 1968), 
with an average transit time in the circulation of 25 hours. A longer monocyte half-time, 
up to 70 hours, has been reported in man (Whitelaw, 1966). In the normal adult, the 
relative peripheral blood monocyte count is generally between 1 and 6 % of the total 
white blood cell count and rarely exceeds 10 %. The absolute monocyte counts in the 
adult ranges between 300 and 700 cells/µl of blood. The migration of peripheral blood 
monocytes into extravascular tissues to become macrophages involves adherence to the 
endothelium, diapedesis between endothelial cells and subsequent migration through 
subendothelial structures (Ley, 1996). Adherence of monocytes to endothelium involves 
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high molecular weight glycoproteins such as lymphocyte function-associated antigen 1 
(LFA-1 also known as CD1la/CD18), which interacts with intercellular adhesion 
molecule-I (ICAM-1 also known as CD54), present on vascular endothelial cells (Dustin 
et al., 1986; Rothlein et al., 1986). Cytokines such as interleukin-I (IL-I) and interferon-
y (IFN-y) increase the expression of ICAM-1 by endothelial cells and can therefore 
facilitate monocyte margination and migration to sites of inflammation (Dustin et al., 
1986). Moreover, during the initial phase of an inflammatory response, the 
promonocytes divide faster and the cell-cycle time of the promonocytes is shorter (10.8 
hours) due to shorter DNA synthesis time, but both return to normal within 24 hours. 
Overall, this process leads to an increase in monocyte counts. 
Inflammation induced changes on monocyte activity and proliferation are mediated by a 
humoral factor present in the circulation, which is called factor increasing 
monocytopoiesis (FIM) (Annema et al., 1992; Shum and Galsworthy, 1982). FIM is a 
monokine that acts as a long-range regulator to signal the bone marrow to increase 
monocyte production during an acute demand for more monocytes and macrophages. 
The fact that FIM is synthesized and secreted by macrophages at the site of inflammation 
implies that macrophages regulate monocyte production by a positive feedback 
mechanism, which leads to an increased number of monocytes in the circulation. 
Monocytes subsequently migrate to the site of inflammation. The proportion of 
monocytes migrating to various organs is apparently random and corresponds roughly to 
the size of the organ. Having arrived at their target organ, the monocytes differentiate into 
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macrophages (Burke and Lewis , 2002; van Furth and Cohn , 1968). Once monocytes 
leave the circulation , however, they do not return and remain in the tissues as 
macrophages for several months. In addition to bone marrow, macrophages are found in 
a variety of locations throughout the body, in addition to the bone marrow , though more 
than 95 % of tissue macrophages derive from monocytes, evidence exists that the 
remaining 5 % of macrophages derive from the local division of mononuclear phagocytes 
in the tissues (Cohen et al., 1995). The latter are not resident macrophages , but have 
arrived in the tissues and body cavities from the bone marrow within the previous 24 
hours , before completion of cell division (van Furth, 1989). Macrophages in tissues and 
body cavities do not compose of constant population of cells, but are being renewed 
regularly by the influx of monocytes. The ultimate fate of tissue macrophages is 
uncertain. The number of macrophages that die must be considerable, because the total 
monocyte production in the mouse, for example, is approximately l.5x10 6 cells over 24 
hours, and all of these cells will eventually leave the bone produce marrow and become 
tissue macrophages (van Furth, 1989). Macrophages from liver, lung and gut are known 
to migrate to nearby draining lymph nodes, but the lymph efferent from these nodes does 
not contain macrophages or monocytes, making it probable those macrophages die in 
lymph nodes. It is also believable that programmed cell death ( apoptosis) occurs in 
tissues and body cavities (Burke and Lewis, 2002). 
Mononuclear phagocytes have different kinetics during inflammatory episodes. During 
an acute inflammatory reaction, the number of circulating monocytes is known to 
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increase due to an enhanced bone marrow production (Burke and Lewis, 2002; Van Furth 
et al., 1973). However, the time spent in the circulation is shorter than under normal 
conditions, due to an efflux of monocytes from the circulation into inflammatory 
exudates. Except for the relatively small share taken by local production during acute 
inflammation, most of the increase in the number of macrophages in the inflammatory 
exudate is brought about by this influx of monocytes (van Furth, 1988). 
Dynamics of Macrophage Function: 
Cells of macrophage lineage are responsible for the secretion of many cytokines and 
assist in the control and fine-tuning of the immune response. Mononuclear phagocytes 
and neutrophils provide the first line of cellular defense against microbial invasion. 
N eutrophils, in general are more efficient phagocytes than macrophages in terms of 
phagocytosis. However, when the particle is large in relation to the cell or when the 
particle load is great, macrophages are more effective (Burke and Lewis, 2002). 
Therefore, macrophages present a major defense against invasion of the host by a wide 
variety of microorganisms including bacteria, viruses, fungi, and protozoa. 
Macrophages have an extensive secretory capability that includes secretion not only of 
enzymes but also of many other biologically active substances. Over 100 substances have 
been reported to be secreted by macrophages (Nathan, 1987). The identification of 
different cytokines is generally associated with the description of a biological action and 
the isolation of peptides that mediate this action. Some of the cytokines produced by 
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macrophages are tumor necrosis factor (TNF), transforming growth factor (TGF), colony 
stimulating factor ( CSF) , interferon (IFN), and interleukin (IL) family of cytokines. 
TUMOR NECROSIS FACTOR (TNF): 
TNF-a was first identified in serum from mice primed with Bacillus Calmette-Guerin 
(BCG) and challenged with endotoxin (Kiger et al., 1980). On transfer to tumor-bearing 
animals , there was an evidence of tumor necrosis. TNF-a, produced by macrophages, 
was later shown to be identical to cachectin, which is responsible for destruction in 
neoplastic and parasitic diseases (Gifford and Flick, 1988). The gene encoding both 
TNF-a and p have been cloned , sequenced and assigned to chromosome 6 near the major 
histocompatibility complex (MHC) loci (Shirai et al., 1985). TNF has also been shown 
to have cytostatic and cytotoxic effects in vitro against a variety of human tumors and to 
be involved in the induction of lL-1, and ICAM-1 (Cerami and Beutler, 1988). TNF-a is 
a multifunctional pleiotropic cytokine with complex biological effects, many of which are 
shared by IL-1. Although other cells, such as T -cells and natural killer (NK) cells can 
also produce TNF-a, macrophages are probably the most important in vivo source of 
TNF-a (Sherry and Cerami, 1988). Similar to IL-1, TNF-a, appears to act in concert 
with other factors, rather than on its own, and is capable of exerting both positive and 
negative effects within the hematopoietic system (Kay and Calabrese, 2004 ). In colony 
assays, TNF is generally found to inhibit growth of bone marrow progenitors for 
granulocyte-macrophages and erythroid cells. The active secreted form of TNF-a is a 
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non-covalently linked trimer of 17-kD monomers, whose crystalline structure has been 
determined (Parrillo et al., 1989; Parrillo, 1993). TNF-a is synthesized as a propeptide, 
with a high degree of cross-species homology in both the propeptide region and the 
mature protein. A membrane-bound form of TNF-a, which may be secreted by 
proteolytic cleavage at the cell surface, has been reported. The genes for TNF-a and th~ 
closely related lymphotoxin (TNF-~) molecule are located within the MHC gene cluster. 
Although both have the same biological effects and bind the same cell-surface receptor, 
the molecules are only 30% homologous at the amino acid level and lymphotoxin is 
produced exclusively by T-lymphocytes, whereas TNF-a is produced mainly by 
mononuclear phagocytes (Tracey et al., 1986). 
Macrophages can be stimulated to produce large amounts of TNF-a by agents such as 
LPS. (Tracey et al., 1986). In vivo, LPS sensitivity is dependent on cells of 
hematopoietic origin and is greatly enhanced in animals with hyperplasia of the 
mononuclear phagocyte system. Moreover, there is direct evidence of TNF production by 
macrophages in vivo, in Mycobacterium bovis bacille Calmette-Guerin (BCG) -induced 
granulomas, and in the inflammatory infiltrate induced by tumors (Mathison et al., 1988). 
It is estimated, for example, that after stimulation with LPS, transcription of the TNF-a 
gene increases 3-fold, whereas mRNA levels rise 50-100 times and protein secretion -
increases by a factor of 1000 (Tracey et al., 1986). 
TNF-a production is closely regulated at multiple levels in macrophages. Of the 
physiological factors that regulate TNF-a production, recombinant IFN-yhas been shown 
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to increase TNF-a, mRNA levels, and dexamethasone, if administered before the onset of 
LPS treatment, can block the induction of TNF-a mRNA (Riedemann et al., 2003; 
Tracey et al., 1986). TNF is cytotoxic for a number of cell lines in vitro. Under certain 
conditions, the cytokine may promote fibroblast growth (Tracey et al., 1986). Cells 
killed by lymphotoxin and TNF-a show a striking fragmentation of nuclear DNA, which 
is suggested to illustrate the major toxic effect. The cytotoxic effect of TNF-a does not 
correlate strictly with target cell receptor ligation, and target cells may modify their own 
responses to TNF-a by changing, for example, their levels of oxidative metabolism 
(Tracey et al., 1986). The effects of TNF-a on other cells in the body at sub-lethal 
concentrations are catabolic and proinflammatory in keeping with the effects of TNF-a 
on living animals. These effects include pro-coagulant effects on endothelial cells, 
changes in adhesive properties of leukocytes, and activation of the microbicidal potential 
of neutrophils and eosinophils (Riedemann et al., 2003; Tracey et al., 1986). On the 
other hand, it has been shown, by using anti-TNF-a antibodies, that TNF-a can increase 
an animal~ s ability to combat an otherwise lethal infection (Lindemann and Economou, 
1988). Thus, regulated TNF-a production, perhaps at sites of local infection, appears 
crucial for host defense while an excess of TNF-a is clearly deleterious to the organism 
(Andrews and Sullivan, 2003; Barthel et al., 2003; Kindler et al., 1989; Marino et al., 
1997; Zganiacz et al., 2004) 
21 
INTERLEUKIN 1 J3 (IL-1~) 
The IL-I family consists of three members: IL- I a, IL-I~ and IL- I receptor antagonist 
(IL-lRa). The former two are responsible for the production of the biological effects 
attributed to this cytokine while IL-lRa is an endogenous inhibitor that blocks the actions 
of the other two members (Arend and Dayer, 1995; Arend et al., 1998; Dinarello, 2000; 
Kay and Calabrese, 2004 ). Both IL- I a and IL- I~ are produced as a 31 kDa precursor 
proteins, termed pro-IL- I a and pro IL- I~' which subsequently cleaved to active proteins 
of 17 kDa by the action of cellular proteases (Kay and Calabrese, 2004 ). IL-I a is 
retained within the cell or expressed on the cell surface and believed to function as an 
autocrine messenger while IL- I~ is secreted and acts on other cells to produce its 
biological actions (Kay and Calabrese, 2004). IL-I~ is the predominant form produced 
by macrophages and found in the circulation (Burger and Dayer, 2002). As a serum 
factor, IL-I acts on the central nervous system to produce fever, somnolence, and 
anorexia. It also stimulates the hepatic acute phase response muscle wasting and bone 
resorption (Strand and Kavanaugh, 2004 ). IL-I is a B-cell chemoattractant and activates 
many neutrophil and macrophage functions. Despite these profound inflammatory 
actions and its synergism with TNF-a in mediating fatal shock, however, IL-I on its own, 
unlike TNF-a, is not a potent cytotoxin or a mediator of generalized vascular collapse 
and shock. 
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SURFACE RECEPTORS 
Receptors on the surface of mononuclear phagocytes determine the control of cellular 
activity including growth, differentiation, activation, recognition, migration, endocytosis 
and secretion. A large number of cell surface molecules are present on the surface of 
monocytes and macrophages by which the macrophage interacts with its environment 
(Gordon et al., 1988). Some of these are growth factor receptors; others are responsible 
for recognition, or adhesion molecules that are important in cellular interactions while 
others are enzymes or receptors for specific ligands important in the role of the 
macrophage. During differentiation and activation, antigens are constantly changing in a 
way orchestrated by genetic programming in response to signals from the extracellular 
environment (Gordon, 1999). 
Over the past 20 years, one of the major aims in LPS research has been the elucidation of 
the sequence of events between the binding of LPS to a cell and the response of the cell. 
One of the first LPS receptors to be characterized was the CDl lb/CD18 or CR3 receptor 
(Wright and Jong, 1986). Binding of LPS-coated erythrocytes to PMN is mediated 
through this receptor. However, it turned out that the cells were not sufficiently activated 
through the CD 11 b/CD 18 receptor, and the quest for identification of the cell-activating 
LPS receptor was continued. In 1990, CD 14 (previously known only as a monocyte-
specific antigen) was identified as the receptor involved in cellular activation (Wright et 
al., 1990). However, because CD 14 lacks a transmembrane signaling domain, the 
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involvement of an accessory receptor was proposed. More recently, the Toll-like 
receptors (TLR) were identified as the putative signaling receptor for LPS , lipoteichoic 
acid (LTA), and a variety of other microbial constituents (Poltorak et al., 1998a). 
Although the precise nature of the CD 14-TLR interactions has not been clarified, the 
events occurring after binding to the TLR are now being unraveled. Moreover, the serum 
proteins LPS-binding protein (LBP) and soluble CD 14 also function as accessory 
receptors to LPS. Recently, we have reported another protein, moesin, to function as a 
receptor to LPS (Tohme et al., 1999). Therefore, it is interesting to note that, there could 
be multiple molecules that can act as receptor for LPS as a complex acting in concert. 
These molecules are CD14, LBP, Toll-like receptors/MD-2 and moesin (Fujihara et al., 
2003; Van Amersfoort et al., 2003). 
CD14 andLBP 
CD 14 served as a marker in identifying cells of the monocyte/macrophage lineage 
(Ferrero and Goyert, 1988). The 55-kDa glycoprotein was identified in 1990 as a 
receptor for the endotoxin, lipopolysaccharide (LPS) that is a major component of the 
outer membrane of gram-negative bacteria (Wright et al., 1990). Immune cells of the 
host recognize minute amounts of LPS and quickly escalate inflammatory defense 
mechanisms. However, an excessive response can induce an overwhelming release of 
cytokines leading to septic shock. 
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The CD 14 molecule is one of the most characteristic surface antigens of the monocyte 
lineage and comprises 356 amino acids anchored to the plasma membrane by a 
glycosylphosphatidylinositol (GPI) linkage without a transmembrane segment and termed 
membrane CD14 (mCD14) (Ferrero and Goyert, 1988; Haziot et al., 1988; Schutt, 1999; 
Simmons et al., 1989). CD 14 is also found free in plasma at 2-6 µg/ml, lacking the GPI 
tail, and referred to as soluble CD14 (sCD14) (Bazil and Strominger, 1991). sCD14 
mediates LPS activation of CD 14-negative cells, such as endothelial and epithelial cells 
(Pugin et al., 1993; Pugin et al., 1994). 
Lipopolysaccharide-binding protein (LBP) was first isolated from rabbit acute-phase 
serum by Tobias et al. (Tobias et al., 1986). They observed differences in the binding of 
LPS to high-density lipoprotein HDL in normal and acute-phase serum and discovered 
that LPS in acute-phase serum was mainly complexed with a protein. The LBP was 
recovered from serum as a 58- and 60.5-kDa protein, the difference in molecular mass 
reflecting different degrees of glycosylation (Ramadori et al., 1990; Tobias et al., 1986). 
LPS and LPS-containing particles (including intact bacteria) form complexes with LBP 
(Schumann et al., 1990). The constitutive levels of LBP in serum are low (1 to 15 µg/ml) 
but increase greatly during infection (Gallay et al., 1993a; Lamping et al., 1998; 
Schumann et al., 1994; Schumann and Zweigner, 1999; Tobias and Ulevitch, 1993). In a 
survey of monoclonal antibodies to macrophage surface antigens, it was noted that 
antibodies to CD14 abrogated the binding of LBP-opsonized particles to the cells, 
suggesting that CD14 is the receptor for LBP-opsonized particles (Schumann et al., 
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1990). LBP binds to the lipid A moiety of LPS (Tobias et al., 1995). The affinity of 
LBP for lipid A is high, with the Kt vaiying from 1 to 58 nM (Gallay et al., 1993b; 
Tobias et al., 1989). The binding site for lipid A is situated in the N-terminal part 
between amino acids (aa) 91 and 108, with positively charged arginine and lysine 
residues within this region fulfilling an essential role (Lamping et al., 1996; Taylor et al., 
1995). The C-terminal part of the LBP molecule, however, mediates the transfer of LPS 
to CD14 (Han et al., 1994b; Schumann et al., 1990; Theofan et al., 1994). 
LBP is a lipid transferase catalyzing LPS transfer from the outer membrane to CD 14, 
thus enhancing the LPS-induced activation of monocytes , macrophages, and Neutrophils 
by 100- to 1,000-fold (Schumann et al., 1990). The role of LBP and CD14 in LPS 
activation of monocytes and macrophages has been demonstrated both biochemically and 
genetically. Immunodepletion of LBP from whole blood lowers the sensitivity of 
monocytes to LPS by at least two orders of magnitude (Schumann et al., 1990). 
Antibodies to CD 14 block LBP-dependent activation of macrophages by LPS (Schumann 
et al., 1990). On the other hand , expression of CD14 on 70Z/3 pre-B cells that are poorly 
responsive to LPS raises their sensitivity to LPS two fold (Lee et al., 1992). Analysis of 
LBP-deficient mice showed that LBP was not necessary in vivo for the clearance of LPS 
from the circulation, but was essential for the rapid induction of an inflammatory 
response by small amounts of LPS or Gram-negative bacteria (Jack et al., 1997). 
However, LBP-deficient mice were significantly more sensitive to Salmonella 
typhimurium infection, indicating that LBP is required to combat infection by Gram-
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negative bacteria. Over expression of human CD 14 in transgenic mice renders these 
mice hypersensitive to LPS, as evidenced by their increased susceptibility to endotoxin 
shock (Ferrero et al., 1993). In contrast, CD14-deficient mice are hyporesponsive to LPS 
and are at least 10 times less sensitive to LPS than normal mice (Cohen et al., 1995). 
These studies demonstrate that LBP and CD 14 are required for monocyte/macrophage 
activation by LPS. Nevertheless, the lack of a transmembrane segment for the 
attachment of CD 14 to the cell surface strongly suggested that CD 14 was not the LPS 
signaling receptor. The theory of the existence of multiple LPS receptors has been 
further reinforced by several lines of evidence, which have demonstrated that CD 14 
blocking monoclonal antibodies only partially inhibit LPS binding (Blondin et al., 1997; 
Fujihara et al., 2003; Lynn et al., 1993; Shapira et al., 1994a; Triantafilou et al., 2000; 
Troelstra et al., 1997; Van Amersfoort et al., 2003). 
The Toll-Like Receptor (TLR) Family 
Due to the absence of a transmembrane signaling domain of CD 14 and the necessity for a 
signaling receptor for sCD 14, the presence of an additional molecule involved in LPS 
binding and signaling was predicted. This putative molecule was discovered after 
cloning of a defective gene in the LPS unresponsive C3H/HeJ mice (Poltorak et al., 
1998a; Poltorak et al., 1998b; Qureshi et al., 1999). This protein was the Toll-like 
receptor 4 (TLR4). Toll was first identified as an essential molecule for embryonic 
patterning in Drosophila and was subsequently shown to be a key in antifungal immunity 
(Guha and Mackman, 2001; Lemaitre et al., 1996). In Drosophila, Toll recognizes 
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pathogens and induces an innate immune response via activation of the Rel transcription 
factors Dorsal , Dif, and Relish (Guha and Mackman , 2001; Imler and Hoffmann , 2000), 
which are homologous to mammalian NF-KB (Imler and Hoffmann , 2000). Toll 
receptors are type I transmembrane proteins that are evolutionarily conserved between 
insects and humans (Beutler , 2001; Lien and Ingalls , 2002). A homologous family of 
Toll receptors , the so-called Toll-like receptors (TLRs) , exists in mammals. Based on the 
similarity in the cytoplasmic portions (designated the Toll-IL-IR, or TIR, domain), TLRs 
are related to IL-1 receptors (IL-lRs). However, the extracellular portions of TLRs and 
IL-lRs are quite different: the extracellular portion of TLRs contains leucine-rich repeats, 
whereas IL-lRs contain three immunoglobulin-like domains. More than ten members of 
the TLR family can be found and ten members (TLR 1-10) have been reported in 
humans (Anderson, 2000 ; Chaudhary et al., 1998; Chuang and Ulevitch, 2000; Du et al., 
2000; Lemaitre et al., 1996; Medzhitov et al., 1997; Rock et al., 1998). The extracellular 
domain of Toll family proteins consist of leucine-rich repeats (LRR) which have been 
implicated in the recognition of pathogens. In mammals, an innate immunity response 
may involve recognition of LPS by one of the TLRs and activation of NF-KB (Medvedev 
et al., 2000). 
Medzhitov et al. ( 1997) showed that a constitutively active mutant of TLR4 containing 
the ectodomains of mouse CD4 and the membrane and cytoplasmic domains of TLR4 
induced the activation of NF-KB and the expression of NF-KB-regulated genes for the 
inflammatory cytokines IL-1, IL-6, and IL-8 (Medzhitov et al., 1997). However , the 
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TLR4 ligand was not identified and the study did not determine if TLR4 mediates LPS 
activation of cells. TLR2 as well as TLR4 are expressed in human monocytes and human 
monocytic cell lines (Medzhitov et al., 1997; Yang et al., 1998) and since TLR2 
signaling depended on LBP and was enhanced by CD14, it was suggested that TLR2 was 
the LPS signaling receptor (Kirschning et al., 1998; Yang et al., 1998). However , these 
findings relied on results from LPS stimulation of TLR2 over expressed in 293 human 
embryonic kidney cells. Over expression of TLRI or TLR4 in 293 cells failed to induce 
NF-KB activation when stimulated with LPS (Kirschning et al., 1998). 
Using the genetic approach to identify the LPS signaling receptor, studies made use of 
two strains of mice, C3H/HeJ and C57BL/10ScCr, which contained a mutation in the Lps 
gene making them hyporesponsive to LPS (Poltorak et al., 1998b; Qureshi et al., 1999). 
It was determined that defective LPS signaling in these mouse strains was due to 
mutations in TLR4, indicating that TLR4 was the LPS signaling receptor (Poltorak et al., 
1998a; Qureshi et al., 1999). Macrophages from mice with a targeted inactivation of the 
TLR4 gene did not respond to LPS (Hoshino et al., 1999), which confirmed the identity 
of TLR4 as the LPS signaling receptor. Finally, using TLR2- and TLR4-deficient mice, 
it was demonstrated that TLR2 and TLR4 recognized cell wall components from Gram-
positive and Gram-negative bacteria , respectively (Takeuchi et al., 1999). A possible 
explanation for the discrepancy in the results with TLR2 might be attributed to possible 
contamination of LPS with highly bioactive endotoxin protein (Hirschfeld et al., 2000). 
Repurification of LPS with a phenol extraction to remove the contaminating proteins 
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eliminated signaling through TLR2, suggesting that the endotoxin proteins may be 
responsible for the TLR2-dependent signaling that was attributed to LPS. 
Myeloid Differentiation Protein-2 (MD-2) 
It was demonstrated that transfection of TLR4 into HEK-293 cells (human epithelial cells 
from kidney) did not confer LPS responsiveness (Shimazu et al., 1999). Therefore, there 
was still controversy about whether TLR4 was sufficient to confer LPS responsiveness. 
It was proposed that another protein might be required for LPS activation of cells via 
TLR4. RP 105 is a B cell-specific receptor that contains LRR repeats similar to 
Drosophila Toll and is involved in B cell activation (Miyake et al., 1995). A new 
protein called MD-1 was shown to physically associate with RP105 (Miyake et al., 
1998). MD-1 was a secreted protein that bound to the cell surface via its interaction with 
RP105. It was hypothesized that an analogous protein may associate with TLR4. A 
search, using the MD-1 amino acid sequence, retrieved a human cDNA clone from an 
expressed sequence tag database (Shimazu et al., 1999). The new protein, named MD-2, 
was also a secreted protein but was associated with the cell surface when expressed in a 
stable cell line expressing TLR4 (Fujihara et al., 2003). These results suggested that 
MD-2 physically associated with TLR4 in a similar manner to MD-1 binding to RP105 
(Kawasaki et al., 2003; Re and Strominger, 2002). Furthermore, expression of MD-2 
enhanced TLR4-dependent activation of NF-KB in transiently transfected 293 cells 
(Miyake, 2004). MD-2 also conferred TLR4-dependent LPS signaling in stably 
30 
transfected Ba/F3 cells, which was inhibited by an anti-TLR4 monoclonal antibody (Asai 
et al., 2003). Another study showed that MD-2 was required for LPS activation of the 
mitogen activated protein kinase (MAPK) pathways (ERK, JNK, and p38), as well as 
Elk-I activity in 293 cells stably transfected with TLR4 (Yang et al., 2000). Finally, a 
TLR4-MD2 complex was identified on the surface of mouse peritoneal macrophages 
(Akashi et al., 2000). Taken together, these results indicated that a TLR4-MD2 complex 
functions as the LPS signaling receptor on the surface of monocytes. However, it is 
currently unknown where and how MD-2 associates itself with TLR4. 
~ 2 - Integrins (CD11/CD18) 
The CD18 antigens, or 32-integrins, compnse a family of three closely related cell 
surface glycoproteins with a varying CDl la-chain and an identical CD18 ~-chain: (i) 
a 1~ 2-integrin, LFA-1 (or CD1la/CD18); (ii) a 2~ 2-integrin, CR3 (complement receptor), 
MAC-1, (or CD1 lb/CD18); and (iii) a 3~ 2-integrin, CR4, (p150,95, or CD1 lc/CD18) 
(Van Amersfoort et al., 2003). LFA-1 is expressed on all leukocytes; CR3 is expressed 
on monocytes, macrophages, PMN, and lymphocytes; while CR4 is expressed abundantly 
on monocytes and macrophages (Wright, 1991 ). LF A-1 recognizes the adhesion 
molecules ICAM-1 and ICAM-2, CR3 recognizes surface-bound C3bi and surface-bound 
fibrinogen, and CR4 binds surface-bound fibrinogen as well (Wright et al., 1988; Wright, 
1991 ). Many strains of E. coli are recognized by macrophages without the intervention 
of antibodies and complement. CD 18 on the surface may be responsible for recognition 
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of the bacteria through the following mechanism: (i) Spreading of macrophages on a 
surface coated with antiCD18 antibodies prevents the binding of E. coli (Wright and 
Jong , 1986), (ii) Spreading of macrophages on a surface coated with Re-LPS or lipid IVA 
prevents the binding of bacteria and C3bi-coated erythrocytes (Wright and Jong, 1986), 
(iii) LPS-coated erythrocytes (E-LPS) bind to macrophages in the absence of LBP, and 
the binding is proportional to the amount of LPS bound to the erythrocytes (Wright and 
Jong , 1986), and (iv) Monocytes from CD18-deficient patients are unable to bind E-lipid 
IV A, E-LPS, and unopsonized bacteria (Wright et al., 1989). Furthermore , all three 
members of the CD 18 family are capable of binding LPS (Monick et al., 2002). The part 
of the LPS recognized by CD18 resides in the lipid A region because Re-LPS and the 
lipid A precursor lipid IV A are recognized. Since the acyl moieties of the LPS are 
embedded in the outer cell wall of the bacteria, only the phosphorylated glucosamines of 
lipid IV A are exposed. Therefore, this is probably the moiety of the LPS molecule that is 
recognized by CD18 (Van Amersfoort et al., 2003; Wright and Jong, 1986; Wright et al., 
1989). This hypothesis is strengthened by the observation that Leishmania mexicana 
lipophosphoglycan, rich in phosphosugars, binds to the same site as LPS on CD 18 
(Talamas-Rohana et al. , 1990). The binding site on the CD18 antigens for LPS is distinct 
from the binding site for endogenous ligands (Wright et al., 1989). In several studies it 
was shown that the activation of mononuclear cells by several microbial antigens, 
including LPS, is partially inhibited by antibodies to CD 18, CD 11 b, or CD 11 c, which 
may indicate that the J32-integrins are involved in cellular activation (Cuzzola et al., 2000; 
Medvedev et al., 1998). CD1 l/CD18 and CD14 may have a common signaling pathway 
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(Golenbock et al., 1993; Ingalls et al., 1997; Ingalls et al., 1998; Perera et al., 2001). 
There are indications that CDl l/CD18 also utilizes the TLR4 pathway for LP-induced 
activation, albeit with substantially lower efficiency, as shown by the differences in 
activation kinetics (Ingalls and Golenbock, 1995; Monick et al., 2002; Perera et al., 
2001). Due to the lower efficiency of CDl l/CD18-TLR4 than of CD14-TLR4, the 
physiological relevance of the former is probably limited (Fujihara et al., 2003; Van 
Amersfoort et al., 2003). 
Moesin 
The cortical actin cytoskeleton that immediately underlies the inner surface of the plasma 
membrane is important both structurally and in relaying signals from the surface to the 
interior of the cell(Fukata et al., 1998; Hirao et al., 1996; Tsukita and Yonemura, 1997a; 
Tsukita and Yonemura, 1997b ). One feature of the actin filaments is that they form a 
tight, regulated association with the plasma membrane (Louvet-Vallee, 2000). ERM 
proteins ( ezrin/radixin/moesin) are located mainly just beneath the plasma membrane of 
cellular protrusions such as microvilli. Initially, ERM molecules were considered as 
structural proteins linking the plasma membrane to the actin cytoskeleton (Bretscher et 
al., 1997; Bretscher, 1999; Bretscher et al., 2000). Later work suggested that ERM 
proteins might also be involved in signal transduction (Bretscher et al., 2002). The 
localization of the ERM proteins has been analyzed in various tissues and cultured cell 
lines. Although ezrin, radixin and moesin are co-expressed in most cultured cells, they 
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exhibit a tissue-specific expression pattern in the whole body (Berryman et al., 1993; 
Franck et al., 1993; Sato et al., 1992). 
Moesin (for membrane organizing extension spike protein) was isolated from bovine 
uterus and characterized as a possible receptor protein for heparin (Lankes and 
Furthmayr, 1991 ). Moesin has a calculated molecular mass is 67.82 kDa and runs in 
SDS/P AGE at 78 kDa where it appears sometimes as a double band on W estem blots 
which is attributed to post-translational modifications (Lankes et al., 1988; Lankes et al., 
1993). Moesin is a 577-amino acid polypeptide. The sequence of the amino-terminal 
halves of the ERM proteins (300 amino acids) is highly conserved. This sequence is also 
found in band 4.1, an erythrocyte membrane protein. Thus, the band 4.1 super family is 
composed of all the proteins sharing a homology with this domain recently called FERM 
domain (for Four point one [4.1] protein, Ezrin, Radixin, Moesin) (Chishti et al., 1998). 
Moesin crystal structure reveals that the FERM domain is composed of three structural 
modules that, together, form a compact clover-shaped structure (Pearson et al., 2000). 
(Figure 1) 
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Figure 1. Moesin Structure. 
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(F-actin binding) 
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C-ERMAD 
Moesin is a 577 amino acid protein which consist of three domains: a globular N-
terminal domain (FERM Domain or N-ERMAD) , an a-helical domain and a positivel y 
charged C-terminal binding domain (C-ERMAD). The N-terminal 296 residues ofmoesin 
fold into a domain that associates with the C-terminal 107 residues of any ERM member. 
The phosphorylation site is in the C-terminal region at threonine 558. 
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Moesin was shown to be phosphorylated on a threonine residue located in the carboxyl-
terminal domain during thrombin activation in platelets (Nakamura et al., 1995; 
Nakamura et al., 1996). Phosphorylation in the carboxyl-terminal domain of radixin 
affects the direct interaction of its carboxyl and amino ERM associated domain (C- and 
N-ERMAD) in vitro. This threonine residue is conserved among the three ERM: Thr558 
for moesin, Thr564 for radixin and Thr567 for ezrin. Moesin is phosphorylated by protein 
kinase C-0 (nPKC-0) and ezrin/radixin by the Rho kinase (Matsui et al., 1998; 
Pietromonaco et al., 1998). This phosphorylation does not affect the binding of ERM to 
actin filaments in sedimentation assay but suppresses the interaction between C-ERMAD 
and N-ERMAD. Immunodetection with an antibody directed against this phosphorylated 
threonine (known as CPERMs) has shown that phosphorylated ERM are highly 
concentrated in microvilli (Yonemura and Tsukita, 1999). Thus, CPERMs represent the 
activated form of ERM proteins. The role of this phosphorylation on Thr558 is confirmed 
by the crystal structure of moesin, which shows that Thr558 is located on helix-C of the 
tail, at the edge of the interface where it is both in contact with the FERM domain and 
exposed to the solvent. The phosphorylation at this position will weaken the helix-
C/FERM interaction due to both electrostatic and steric effects (Pearson et al., 2000). 
In their non-phosphorylated state ERM proteins are present as monomers (Figure 2) and 
have no site available for interaction with other molecules due to the intramolecular 
interaction (head to tail phenomenon). Thus, one possible mechanism of inactivation is 
the phosphorylation/ dephosphorylation of the activated ERM (Louvet-Vallee, 2000). It 
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1s the case for apoptosis when eznn 1s inactivated by dephosphorylation on 
serine/threonine residues. This dephosphorylation results in a cytoplasmic translocation 
of the protein with concomitant microvilli breakdown (Kondo et al., 1997). In vitro 
experiments have demonstrated that the amino-terminal domain of ezrin and moesin 
interact with the myosin-binding subunit (MBS) of myosin phosphatase (Fukata et al., 
1998). In MOCK cells, moesin and MBS co localize in the TP A induced membrane 
ruffles and they can be co-immunoprecipitated. Moreover , MBS is able to 
dephosphorylate the Thr558 of moesin (Fukata et al., 1998). 
a) b) 
c) d) 
Figure 2. Head-to-Tail interactions of the ERM Proteins. 
Possible conformations of moesin brought about by N and C -terminal association domains 
(ERMAD) interactions. These include (a) folded monomeric molecule, (b) unfolded monomeric, 
(c) dimeric [lzomodimeric, e.g. moesin and moesin, or heterodimeric, e.g. moesin and ezrin}, and 
(d) oligomeric [e.g. moesin and radixin}. 
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Recently it has been shown that moesin is also involved in LPS signaling (Tohme et al., 
1999). Experiments using anti-moesin monoclonal antibody blocked LPS induced TNF-
a, release by monocytes while LPS binding was not blocked. Also it was shown that LPS-
induced skin lesions exhibited a three fold reduction of neutrophil infiltrate in moesin-
knock out mice compared to wild type mice.(Amar et al., 2001). Moreover, anti-moesin 
antibody did not inhibit S. aureus-mediated and recombinant IL- I ~-mediated effects. 
These results demonstrate the specificity of moesin to LPS (Tohme et al., 1999). 
Therefore, it is tempting to consider that moesin may represent another component in the 
CD14-TLR4 signaling pathway. 
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PATHWAYS OF LPS SIGNALING 
In the last 5 years, the understanding of intracellular signaling pathways coupled with 
LPS stimulation has progressed tremendously. This is a result of two important 
contributions. First was the identification of the Toll-like receptor (TLR) family based 
upon homology with the Drosophila TOLL protein (Gay and Keith, 1991; O'Neill and 
Greene, 1998; Rock et al., 1998). The second important finding was the demonstration 
that LPS sensitivity in mice was encoded in the TLR4 gene (Poltorak et al., 1998b; 
Qureshi et al., 1999). TLR2 has also been implicated in signaling from LPS and from a 
subset of other microbial products known to stimulate robust pro-inflammatory 
macrophage activation responses (Kirschning et al., 1998; Schwandner et al., 1999; 
Takeuchi et al., 1999). The first member of this family identified in vertebrates was IL-1 
receptor type I (IL-Rl) (O'Neill and Greene, 1998). The predominant feature of the IL-
Rl and other TLR family members is a protein-protein interaction domain (Toll domain) 
which is essential for initiation of the signaling cascade following receptor aggregation 
(O'Neill and Greene, 1998). The TLR domain mediates binding of a second TLR 
domain-containing factor termed MyD88. Downstream sequential components include 
one or more members of the IL-1 receptor-associated kinase (IRAK) and TRAF6. The 
latter can couple with several protein kinase cascades including NF-KB inducing kinase 
(NIK) and similar MAP kinase modules, RAS, RAF and downstream targets (Hambleton 
et al., 1995; Hambleton et al., 1996; O'Neill and Greene, 1998). This divergence 
provides at least one opportunity for generating multiple, partially independent response 
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pathways. NIK and potentially MAPK module components are able to activate IKB 
kinase complex, leading to release of active NF-KB (May and Ghosh, 1998; O'Neill and 
Greene, 1998; Wajant et al., 1999). These protein kinase cascades lead to the activation 
of multiple additional factors, which regulate the process of gene expression by both 
transcriptional and post-transcriptional mechanisms. Many components of the IL-1 
signaling pathway are shared, with TNF-initiated events accounting for the substantial 
overlap in functional responses to these two agents. 
Regulation of Nuclear Factor (NF) 1CB Activity 
LPS stimulation of macrophages results in the activation and assembly of multiple 
transcription factors to adjacent sites in the promoters of LPS-inducible genes. It was 
shown that assembly NF-KB/Rel proteins on the tissue factor promoter is required for 
maximal induction of gene expression in THP-1 cells (Guha and Mackman, 2001; 
Mackman et al., 1991; Sweet and Hume, 1996). These transcription factors are activated 
by phosphorylation, which permits the rapid induction of gene expression in response to 
LPS. NF-KB/Rel proteins appear to be essential for the induction of all LPS-inducible 
genes in monocytes (Muller et al., 1993). (Figure 3) 
NF-KB activation has been reported to involves regulation of transactivation activity of 
p65 and c-Rel. D609, a phosphatidylcholine-specific phospholipase C (PC-PLC) 
inhibitor, reduced nuclear NF-KB-dependent transcription without affecting the cytokine-
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induced nuclear translocation and DNA binding of NF-KB (Bergmann et al., 1998; Cobb 
et al., 1996). Similarly, LPS induction of NF-KB-dependent gene expression in THP-1 
cells was blocked by the protein tyrosine kinase inhibitor genistein without affecting 
nuclear translocation of NF-KB (Y oza et al., 1996). Other studies showed that specific 
inhibitors of the ERK (p4/42) and p38 MAPK pathways blocked nuclear NF-KB activity 
and the transactivation activity of p65 (Beyaert et al., 1996; Vanden Berghe et al., 1998). 
However , these studies did not establish the downstream targets of these signaling 
pathways required for NF-KB activity. Possible targets of these pathways include p65 
itself, co activators such as CBP/ p300 and subunits of the RNA polymerase II complex. 
Moreover, TNFa-induced phosphorylation of p65 was not modulated by the p38 
inhibitor SB203580 (Rutault et al., 2001). A recent study showed that inhibition of the 
p3 8 pathway significantly reduced the binding of TAT A-binding protein (TBP) to the 
TATA box (Beyaert et al., 1996; Carter et al., 1999a), suggesting that inhibition of p38 
reduced NF-KB activity by affecting the basal transcriptional complex rather than by 
directly affecting NF-KB itself. Several studies have shown that p65 is activated by 
phosphorylation (Yang et al., 2003; Zhong et al., 1997). The catalytic subunit of protein 
kinase A (PKA) was shown to be bound to inactive NF-KB complexes in the cytosol and 
upon degradation of the Inhibitor-KB (IKB) this catalytic subunit phosphorylated p65 at 
serine 276 in the N-terminal Rel homology domain, resulting in an enhanced 
transcriptional activity (Zhong et al. , 1997). The small OTP-binding protein Ras 
enhanced p65 transcriptional activity through a pathway that required the p3 8 kinase 
pathway or a related kinase (Norris and Baldwin, 1999). Ras and the atypical protein 
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kinase C l; phosphorylated the Rel homology domain of p65 and enhanced the 
transcriptional activity of p65 (Anrather et al., 1999). p65 and c-Rel also contain C-
terminal transactivation domains. p65 transactivation domain was activated by 
phosphorylation (Bull et al., 1990; Naumann and Scheidereit, 1994; Schmitz et al., 
1995). Activation of NF-KB-dependent transcription by TNFa is mediated through 
phosphorylation of serine 529 in the transactivation domain of p65 (Wang and Baldwin, 
1998). It was proposed that serine 536 in the transactivation domain of p65 was the 
major site of TNFa-inducible phosphorylation (Sakurai et al., 1999). TNFa induced 
phosphorylation of serine 4 71 in the transactivation domain of c-Rel also appears to be 
required for its activation. Characterization of a mutant clone of the Jurkat cell line that 
fails to activate NF-KB upon TNF a stimulation demonstrated a defect in the immediate-
late translocation of c-Rel to the nucleus (Martin and Fresno, 2000). When sequencing of 
the c-Rel gene from this clone it was revealed a mutation in serine 4 71 in the 
transactivation domain. Importantly, unlike the wild-type c-Rel, mutant S471N could not 
be activated by TNFa. Rael has been shown to regulate IL-I-induced NF-KB activation 
by enhancing the transactivational activity of p65 (Hawiger, 2001; Jefferies and O'Neill, 
2000). 
The Inhibitor 1CB Kinase (IKK) Pathway 
Many studies have demonstrated that LPS activates NF-KB in human monocytes and 
monocytic cell lines (Muller et al., 1993; Takashiba et al., 1995; Takashiba et al., 1999). 
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However, the intracellular signaling molecules that mediate this activation had not been 
elucidated. LPS activation of NF-KB in human THP-1 monocytic cells is inhibited by 
dominant-negative mutants of MyD88, IL-1 receptor-associated kinase (IRAK), and 
TNFa receptor-associated factor (TRAF6) but not by dominant negative TRAF2 (Zhang 
et al., 1999). In addition, IRAK does not associate with MyD88 in LPS-tolerant THP-1 
cells. Genetic evidence confirms a role of MyD88 and TRAF6 in LPS signaling (Hoebe 
et al., 2003; Lomaga et al., 1999) and MyD88-deficient mice lack the ability to respond 
to LPS as measured by the secretion of cytokines by macrophages (Lomaga et al., 1999). 
Also, TRAF6-deficient mice were hyporesponsive to LPS. Taken together, these data 
indicate that MyD88, IRAK, and TRAF6 play a role in LPS signaling in monocytes and 
macrophages (Aderem and Ulevitch, 2000). 
I KB kinase (IKK) complex has been purified, cloned and found to consist of two 
homologous catalytic subunits (IKKa and IKKJ3) (DiDonato et al., 1997; Mercurio et al., 
1997) and a non-catalytic subunit, IKK.y, also known as NEMO) (Yamaoka et al., 1998). 
NF-KB activation either by LPS or by cytokines, such as IL-1 and TNFa, requires NF-KB 
inducing kinase (NIK) activation (Israel, 2000). The IKKs are thought to be activated 
through phosphorylation by an upstream kinase(s). Candidates for this kinase include 
NIK and mitogen-activated protein kinase ERK kinase kinase 1 (MEKK.1) because each 
of these kinase can activate NF-KB through phosphorylation and activation of the IKKs 
(Bergmann et al., 1998; Lee et al., 1997; Nakano et al., 1998). In addition, dominant 
negative mutants of NIK, MEKK.1, and the kinases TAKI (transforming growth factor~-
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associated kinase 1) inhibit LPS activation of NF-KB and TNFa promoter activity in 
mouse RAW 264.7 cells (Irie et al., 2000; Swantek et al., 1999). However, a role for 
NIK has recently been disputed because analysis of alymphoplasia mice that contain a 
point mutation in NIK showed no defect in NF-KB activation by TNFa (Shinkura et al., 
1999). More recently, a novel protein linking TRAF-6 to MEKKl was discovered that 
was called Evolutionarily Conserved Signaling Intermediate in Toll pathways (ECSIT) 
(Kopp et al., 1999). This adapter protein is specific for the TolVIL-1 pathways and is a 
regulator of MEKKl processing. Another study reported an adaptor protein called T AB2 
that mediates activation of TAKI by linking TAKI to TRAF6 (Takaesu et al., 2000). A 
novel kinase, IKKi, is LPS inducible in RAW 264. 7 cells and shows 30% identity to 
IKKa and IKK~ (Shimada et al., 1999). Overexpression of IKKi activated NF-KB. 
However, the role of IKKi in LPS signaling is yet to be established. 
It was shown that LPS activates the IKKs in human monocytes, THP-1 monocytic cells, 
and mouse RAW 264.7 cells (Fischer et al., 1999; Hawiger et al., 1999; O'Connell et al., 
1998; Swantek et al., 1999; Yang et al., 2003). The kinetics of LPS activation of the 
IKKs are relatively slow (peaking at about 30min) compared with TNFa activation of the 
IKKs (peaking at about 5 min), which suggested that different signaling pathways were 
involved in the activation by these two agonists (Fischer et al., 1999; Guha and . 
Mackman, 2001; Hawiger et al., 1999; O'Connell et al., 1998). Furthermore, it was 
demonstrated that a dominant-negative mutant of IKK~ inhibited LPS induction of NF-
KB-dependent gene expression and TNFa promoter activity whereas a dominant-negative 
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mutant of IKK.a had no effect (O'Connell et al., 1998). More recently, knockout of the 
IKK.a and IKK.f3 genes yielded remarkably different phenotypes (Anrather et al., 1999; 
Hoshino et al., 1999). Disruption of the IKK.f3 gene results in embryonic lethality caused 
by severe liver degeneration during midgestation, a phenotype consistent with excess 
TNF a toxicity, whereas disruption of the IKK.a gene results in abnormal morphogenesis. 
The phenotype of IKK-deficient embryos is remarkably similar to that of p65-deficient 
embryos (Beg et al., 1995). It was concluded from these results and studies using IKK.a 
and IKK.f3 deficient fibroblasts that IKK.f3, but not IKK.a, was required for TNFa and IL-
1 signaling (Anrather et al., 1999). These studies support the conclusion that IKK.f3 is 
required for LPS activation of NF-KB in THP-1 monocytic cells (Guha and Mackman, 
2001; Yang et al., 2003). 
Mitogen-Activated Protein Kinase (MAPK) Pathways 
Many upstream activators are involved in LPS signaling in monocytes. LPS stimulation 
of monocytes/macrophages induces the rapid tyrosine phosphorylation of proteins, 
including the src tyrosine kinase family members' p53/56lyn, p58/64c-fgr (Henricson et 
al., 1995; Shapira et al., 1994b; Stefanova et al., 1993). LPS also activates typical 
(PKCf3) and atypical (PCK~) isoforms of protein kinase C (Herrera-Velit et al., 1997; 
Shapira et al., 1994b ). In addition, pertussis toxin inhibited LPS-induced responses in the 
P3 88D 1 mouse macrophage line, indicating that the G-proteins Gi and transducin are 
involved in LPS activation (Jakway and DeFranco, 1986). These and other signaling 
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molecules may mediate activation of the MAPK pathways. Indeed, LPS is a potent 
activator of all three MAPK pathways in human monocytic cells (Sweet and Hume, 
1996). MAPK cascades are composed of a MAPK, MAPK kinase (MAPKK), and a 
MAPKK kinase (MAPKKK). 
Members of the MAPK family of protein kinases include the p42 and p44 extracellular 
signal receptor kinases (ERK.s), the c-Jun N-terminal kinases (JNKs), and the p38 kinases 
(Davis, 1999; Hale et al., 1999; Minden and Karin, 1997). All MAPKs are activated by 
phosphorylation of conserved threonine and tyrosine residues that are present in distinct 
triads in kinase domain VII: TPY for JNKs, TEY for ERK.s, and TGY for p38 kinases 
(Beyaert et al., 1996; Hale et al., 1999). The MAPKs are likely to be associated with 
their upstream activators and their downstream targets via molecular scaffolds that 
enhance transduction of signals from the plasma membrane to the nucleus and may be 
further regulated by association with phosphatases (Whitmarsh et al., 1998). The ERK.s, 
JNKs and p3 8 kinases influence gene transcription based on their ability to phosphorylate 
and activate multiple transcription factors including c-Jun, JunD, ATF-2, Sap-la, and 
Elk-1 In combination with each other and with other transcription factors (e.g., NF-KB), 
these proteins bind to critical regions in the promoters of genes that are important for cell 
growth and for inflammatory responses (Carter et al., 1999b; Davis, 1999; Gupta et al., 
1996; Ip and Davis, 1998; Janknecht and Hunter, 1997; Minden and Karin, 1997; 
Rahmsdorf, 1996; Su and Karin, 1996; Whitmarsh et al., 1998; Wilkinson and Millar, 
1998; Yuasa et al., 1998). 
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Figure 3. Recognition and intracellular events in LPS stimulated macrophages. 
LPS binding protein (LBP) is the plasma protein that firstly interacts with and recruits 
LPSfrom bacterial membrane to another protein CD14. CD14, which is present in 
plasma as well as on the monocytelmacrophages cell surface, binds to LPS and facilitates 
its signaling. CDJ 4 is a glycosylphosphatidylinositol (GPI)-anchored protein and does 
not have a cytoplasmic signaling domain. Another molecule was found to transmit the 
LPS signal across the plasma membrane. CD14 was found to come into the proximity of 
another molecule, the Toll-like receptor-4 (TLR4). TLR are transmembrane molecules 
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consisting of extracellular leucine-rich repeats (LRRs) and an intracellular signaling 
domain, which is similar to the type I IL-1 receptor. TLR4 alone however is not capable 
of sensing and signaling the presence of LPS. Another molecule MD-2, which is 
physically associated with TLR4 , is required for LPS recognition. The TLR4-MD-2 
complex then recruits the adaptor protein MyD88 which in turn recruits and activates IRAK-
1 through their prospective death domains. !RAK subsequently autophosphorylates and 
dissociates from MyD88 and interacts with TRAF6. TRAF6 then activates two main down stream 
signaling cascades; IKK, bdla and NF-1dJ, and MAP Kinase. This leads to the transcription and 
secretion pro-inflammatory cytokines (e.g. TNFa). 
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SPECIFIC AIMS 
Several receptors have been implicated in the recognition of LPS. The inhibition of 
TNFa by moesin antibodies and decrease inflammatory infiltrate in moesin knock-out 
mice suggest that moesin plays an important role in the intracellular signaling of 
monocytes/macrophages upon LPS challenge. 
Given these facts, the overall aim of this study is to characterize and investigate moesin 
mediated intracellular events in LPS-stimulated mononuclear phagocytes. 
The specific aims are: 
• Characterization of cell surface expression of moesin. 
• Regulation of moesin at the protein and RNA levels. 
• Protein-protein interaction between TLR4, MD-2, MyD88, and moesin. 
• Characterize intracellular mediated events using 
o IKB Kinase activity and subsequent activation and translocation ofNFKB. 
o MAP Kinase activity. 
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MATERIALS AND METHODS 
Reagents / Materials 
The human promonocytic cell line THP-1, Vita cell RPMI 1640 cell culture medium and 
Fetal Bovine Serum (FBS) were obtained from the American Type Culture Collection 
(ATCC, Manassas , VA). Macrophage serum free medium (M-SFM) and Trizol were 
obtained from Invitrogen Life Technologies (Carlsbad, CA). TaqMan probes, sense 
primers , and anti-sense primers of moesin and ~-actin were obtained from Applied 
Biosystems (Foster City, CA). Dithiothreitol (DTT), Sodium pyrophosphate, ~-
Glycerolphosphate , Sodium Orthovanadate (Na3 VO4), Leupeptin , Phorbol 12-myristate 
13-acetate (PMA) , phenylmethylsulphonylfluoride (PMSF), E. coli LPS (strain O55:BS), 
moesin affinity purified mouse monoclonal antibody (IgG1) clone 38/78 were purchased 
from Sigma (St. Louis, MO). X-Omat Blue (XB) Film was purchased from PerkinElmer 
(Boston, MA). IRAK monoclonal antibody (recognizes active IRAK at 100 KDa) was 
from BD Pharmingen (San Diego, CA). Rabbit anti-IRAK antibody was from Upstate 
USA, Inc. (Charlottesville , VA). MyD88 antibody (agarose conjugated goat lgG), 
protein A/G plus agarose, affinity purified TLR4 rabbit polyclonal antibody, affinity 
purified MD-2 rabbit polyclonal antibody, affinity purified rabbit polyclonal phospho-
moesin antibody, affinity purified CD14 monoclonal antibody, TRAF6 monoclonal 
antibody, phospho-threonine specific antibody, actin monoclonal antibody as well as 
Horseradish Peroxidase (HRP) and Fluorescein Isothiocyanate (FITC) conjugated 
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appropriate secondary antibodies were purchased from Santa Cruz (Santa Cruz, CA). 
SuperSignal West Pico Chemiluminescent Substrate was form Pierce (Rockford, IL). 
NF-KB Active ELISA kit was purchased from Imgenex (San Diego , CA). TNF-a and 
IL-1~ ELISA kits were purchased from R&D systems (Minneapolis , MN). p38 and 
ERK.1/2 (p4/42) MAP Kinase activity, phospho-specific IKBa antibody, anti-mouse and 
anti-rabbit HRP-conjugated secondary antibody and LumiGlu Chemiluminescence 
substrate were from Cell Signal (Beverley , MA). P38 inhibitor SB202190 and p44/42 
inhibitor PD98059 (Ajizian et al., 1999; Guha et al., 2001; Manthey et al., 1998; Rutault 
et al., 2001) were purchased from Calbiochem (La Jolla, CA). Zenon Alexa Fluor 488 
IgG 1 labeling reagents and Prolong antifade mounting kit were purchased from Molecular 
Probes, Inc. (Eugene, OR). Nunc Lab-Tek II chamber slide system was purchased from 
Fisher (Fisher Scientific, Suwanee, GA). Polyvinylidene difluoride (PVDF) transfer 
membrane (Millipore Corp., Bedford, MA). Protein assay reagent and electrophoresis 
apparatus (separation and blotting) were purchased from Bio-Rad (Hecules, CA). Unless 
other wise specified, all reagents were purchased from Sigma (St. Louis , MO). 
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EXPERIMENTAL PROCEDURES 
Cell Culture, Differentiation, Stimulation and Lysing 
THP-1 cells were cultured in Vita cell RPMI 1640 supplemented with 10% fetal bovine 
serum, 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate , 4.5 g/L 
glucose, 10 mM HEPES and 1.0 mM sodium pyruvate and 0.05 mM (3-Mercaptoethanol. 
Cells were cultured at 3 7°C in a 5% CO2 atmosphere. Cells were kept at a concentration 
of 5-8 x 106 by logarithmic sub culturing every 3-4 days, either by addition or 
replacement of fresh medium. THP-1 cells are premonocytes, committed to the 
monocytic cell lineage. They grow in suspension and do not adhere to the plastic 
surfaces of the culture plates . To induce differentiation into macrophage-like cells, THP-
1 cells were plated in 6, 12 or 24 well tissue culture plates and treated with 20ng/ml PMA 
for 18-24 hours (Takashiba et al., 1999; Tsuchiya et al., 1982). FACS analysis 
confirmed increased expression of CD 14, a macrophage-specific differentiation antigen, 
compared to untreated THP-1 cells (Figure 4). Non-adherent cells were washed with 
phosphate buffered saline (PBS) and adherent cells were subjected to the designated 
experimental condition. Adherent cells were incubated for different time points with 
several concentrations of E. coli LPS. Peak response from LPS stimulation was 
predetermined based on pilot dose response experiment. For blocking experiments, cells 
were pre-incubated with moesin monoclonal (l0µg/ml) or an isotype-matched control 
antibody prior to their LPS stimulation. The anti-moesin antibody concentration was 
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predetermined based on pilot dose response. After stimulation, cells were lysed for 20 
minutes on ice with ice-cold lysis buffer (Cell Lysis Buffer: 20 mM Tris (pH 7.5), 150 
mM NaCl , 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM Sodium 
pyrophosphate, 1 mM beta-Glycerolphosphate, 1 mM Na3 VO4, 1 µg/ml Leupeptin, 1 mM 
PMSF). Cell viability was continuously assessed and <95% of the cells were trypan-
blue-positive during different stages of incubation and stimulation. 
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Expression of Moesin on Differentiated THP-1 Cell Surface by Confocal 
Immunofluorescence Microscopy 
Moesin monoclonal antibody was labeled using the Zenon Alexa 488 protein labeling kit 
(final antibody concentration of 2.5µg/ml) according to the manufacturer's instructions 
(Molecular Probes, Inc., Eugene, OR). Briefly, lµg of either moesin or an isotype-
matched control antibody were diluted in PBS and 5µ1 of Zenon mouse lgG 1 labeling 
reagent was added and incubated for 5 minutes at room temperature. 5 µl of Zenon 
blocking reagent was then added to the reaction mixture. THP-1 cells were seeded in a 
chamber slide system and treated with 20ng/ml PMA for 24 hours. After differentiation, 
the non-adherent cells were washed with M-SFM and the adherent cells were stimulated 
with LPS in M-SFM. Cells were then washed with PBS and fixed with 4% 
paraformaldehyde for 15 minutes at room temperature. For membrane permeabilization, 
cells were incubated with 0.1 % Triton X-100 in PBS for 5 minutes at room temperature 
after fixation. After washing with PBS, the cells were then incubated with 10% normal 
goat serum in PBS for 30 minutes followed by incubation with either moesin antibody or 
an isotype-matched control antibody (Zenon labeled complex) in PBS with 10% normal 
goat serum for 60 minutes at room temperature protected from light (final antibody 
concentration 2.5µg/ml). Cell samples were then washed 2 times with PBS and fixed 
again in 4% paraformaldehyde solution in PBS for 15 minutes at room temperature. 
Antifade mounting kit (ProLong) was used and the cells were examined using a laser 
scanning confocal microscope (Leica Microsystems Heidelberg, Germany). 
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FACS Analyses 
Differentiated THP-1 cells were stimulated in culture with several concentrations of LPS 
(10, 100 and 1000 ng/ml) at different time points (resting, 5, 15, 30 and 60 minutes, 2, 4, 
6 and 24 hours). All staining and washing procedures were perfonned at 4 °C with 
staining buffer (2% FBS in PBS). Cells were incubated with moesin monoclonal 
antibody (I0µg/ml) for 30 minutes. After washing, cells were further incubated with 
FITC-conjugated secondary antibody (40µg/ml, Santa Cruz Biotech, CA) for 30 minutes. 
For control experiments, cells were either incubated with an isotype-matched control 
primary antibody or only FITC-conjugated secondary antibo~y. Data were acquired and 
analyzed on F ACScan using Cell Quest software (BD Bioscience, Franklin Lakes, NJ). 
SDS-PAGE and Western blot Analysis 
To investigate moesin total protein regulation and phosphorylation, after stimulation, 
cells were lysed for 20 minutes on ice with cold lysis buffer. Cell lysates were sonicated 
for 10 seconds (on ice). Supernatant (whole cell lysates) was collected by centrifugation 
at 13,000 rpm (16,000 xg) for 15 minutes at 4°C and the protein content of cell lysates 
was determined by the Bradford assay using the Bio-Rad protein reagent (Bradford, 
1976). Samples were mixed in Laemmli sample buffer (Laemmli, 1970) (62.5 mM Tris-
HCl (pH 6.8 at 25°C), 2% w/v SDS, 10% glycerol, 50 mM DTT, 0.01 % w/v 
bromophenol blue) and then boiled for 5 minutes. Five micrograms of protein per lane 
were separated with 10% SDS-PAGE in running buffer (25mM Trizma base, 192mM 
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Glycine, 0.1 o/oSDS) at 150 volts. After electrophoresis, proteins were transferred onto 
polyvinylidene difluoride (PVDF) membranes in a Tris-glycine-20% methanol buffer 
(25mM Trizma base, 192mM Glycine, 20% Methanol) for 1 hour at 4 °C and 400m 
Amperes. Membranes were then blocked in 5% skim milk for one hour at room 
temperature in Ttris-buffer-saline (1 0mM Tris, pH 7 .6, 150mM NaCl) with 0.1 % Tween-
20 (TBS-T). The blocked membrane was incubated with either moesin monoclonal 
antibody (0.5µg/ml) (Sigma , St. Louis, MO) or phosphospecific moesin antibody (1:1000 
dilution) (Santa Cruz, Santa Cruz, CA) in 5% skim milk in TBS-T. After washing with 
TBS-T , 3 times 10 minutes each, the membrane was incubated with the appropriate HRP-
conjugated secondary antibody (1:10,000 dilutions) in 5% skim milk in TBS-T. 
lmmunodetection was accomplished using an enhanced chemiluminescence system 
(Pierce Biotechnology, Rockford, IL). Semi-quantitative analysis of the autoradiograms 
was assessed by the Bio-Rad imaging system using their software (Bio-Rad, Hercules, 
CA). 
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RNA preparation, Reverse Transcription and Quantitative (real-time) polymerase 
chain reaction (PCR) 
After stimulation with or without LPS, total RNA was isolated by extraction with Trizol 
using the standard procedure supplied by the manufacturer (lnvitrogen) and quantified by 
spectrometry at 260 and 280 nm (Bio-Rad). cDNA first strand synthesis was carried out 
from approximately 50ng of total RNA primed with random hexamers and reverse 
transcribed using AML-V reverse transcriptase (TaqMan, ABI Prism) in 10 µl reaction 
mixes. Reaction mixes were subjected 25°C for 10 minutes , 48°C for 30 minutes and 
95°C for 5 minutes in a thermal cycler (ABI 9700). Reverse transcription products were 
prepared in 10 ng duplicates and real-time preformed using primers and TaqMan probes 
labeled with MGB-F AM dye specific for human moesin (Applied Biosystems, Assays-
on-demand). Standards for moesin and ~-actin were obtained from a 10-fold serial 
dilution of THP-1 cells cDNA. Human ~-Actin was selected as an endogenous control 
and amplified using pre-formulated VIC-TAMRA labeled TaqMan probes (Applied 
Biosystems, Endogenous Control). Quantification was performed in an automated 
thermalcycler (ABI Prism 7000) according to PCR standard protocols and the results 
analysed through a software interface and Excel spreadsheet for calculation of relative 
expression normalized to J3-Actin. Experiments were performed in duplicates for each 
data point. 
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Immunoprecipitation 
Cell lysates (0.5-lmg) were pre-cleared with normal mouse lgG and protein A/G agarose 
beads for 1 hour at 4°C followed by overnight immunoprecipitation with Goat anti-
moesin polyclonal antibody ( 1 µg/ml) and protein A/G agarose beads (20µ1). Beads were 
collected by centrifugation for 30 seconds and washed 3 times with lysis buffer and 
resuspended sample buffer then boiled for 5 minutes followed by SDS-PAGE. Western 
blots were developed with anti TLR4 (1 :500 dilution), MD-2 (1 :750 dilutions) or~ -actin 
antibody (1 :250 dilutions). HRP-conjugate was used as the developing agent. Proteins 
were visualized on X-ray film using the Pierce chemiluminescence system (Pierce 
Biotechnology, Rockford, IL). Results were confirmed in 3 independent experiments. 
MyD88-IRAK and IRAK-TRAF6 Co-immunoprecipitation Assay 
One µg of the normal goat lgG was added together with 20 µl of protein A/G plus 
agarose to approximately 1 ml of whole cell lysate (0.5-lmg/ml protein concentration), 
and incubated at 4 °C for 60 minutes. Beads were pelleted by centrifugation at 1,000xg 
for 30 seconds at 4 °C and supernatant (Pre-Cleared Cell lysate) was transferred to a fresh 
microcentrifuge tube. 10 µg of MyD88 antibody agarose-conjugate was then added and 
incubated at 4 ° C for overnight with mixing. Beads were collected by centrifugation and 
supernatant was carefully discarded. Beads were washed with lysis buffer 3 times and 
then the pellet was resuspended in 50 µl of SOS-sample buffer. After boiling, samples 
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were loaded on 10% gels. After electrophoresis, W estem blotting using IRAK antibody 
(BD Pharmingen , San Diego, Ca) at 1 :500 dilution, was performed as mentioned earlier. 
For IRAK-TRAF6 co-immunoprecipitation, 4 µg IRAK rabbit lgG was incubated with 
the cell lysates overnight at 4 °C. protein A/G beads were then incubated with the lysated 
for 2 hours at 4°C. Beads were collected and washed as described earlier. After transfer, 
PVDF membranes were probed with TRAF6 monoclonal antibody (1: 1000 dilution). 
IRAK phosphorylation assay 
To further confirm the role of moesin, IRAK phosphorylation was studied. IRAK rabbit 
lgG (8µg/ml) was incubated with cell lysates over night at 4 °C followed by adding 20µ1 
of A/G protein agarose beads and incubation for another 2 hours. Beads were washed 3 
times with lysis buffer and then resuspended in SOS-sample buffer. After boiling, 
samples were loaded on 8% gels. After SDS-PAGE and transfer, membranes were 
probed with phospho-threonine specific antibody (1 :750 dilution). 
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MAPK Activity Assay 
Differentiated THP-1 cells were stimulated with LPS in 12-well tissue culture plate. For 
blocking experiments , cells were pre-incubated with anti-moesin monoclonal or an 
isotype-matched control antibody as mentioned earlier. After LPS stimulation, media 
was aspired and cells were rinsed once with ice-cold PBS. Cells were lysed for 5 minutes 
by adding 0.5 ml ice-cold Cell Lysis Buffer to each well. Cells were scarped off the plate 
and transferred to a microcentrifuge tubes. Cell lysates were sonicated 4 times for 5 
seconds each on ice. Samples were then microcentrifuged at 13,000 rpm (16,000 g) for 
15 minutes at 4 °C, and supernatant was then transferred to a new tube. Protein 
concentration of each sample was adjusted to lmg/ml. MAP activity assay was 
performed according the manufacturer's instructions (Cell Signal, Beverly, MA). 
Briefly, samples were incubated with either immobilized phospho-specific monoclonal 
antibodies to p44/42 or p-38. For SAPK/JNK a c-Jun fusion protein was used to "pull 
down" SAP Kinase. After overnight incubation, beads were microcentrifuged for 30 
seconds at 4 °C and the pellet was washed twice with 500 µl of lysis buffer followed by 
two washes with 500 µl of kinase buffer (25 mM Tris-HCl (pH 7 .5), 5 mM P-
glycerophosphate, 2 mM dithiothreitol (DTT), 0.1 mM Na3 V0 4, 10 mM MgCh). Beads 
were then suspended in 50 µl kinase buffer supplemented with 200 µM ATP and 2 µg 
Elk-1 fusion protein for p44/42, 2µg ATF-2 fusion protein for p-38 or only lO0µM ATP 
for SAP/c-Jun. this was followed by incubation for 30 minutes at 30°C. the reaction was 
terminated by adding 3x SDS sample buffer. Samples were then boiled for 5 minutes, 
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vortexed and then microcentrifuged for 2 minutes. 30 µl from each sample was then 
loaded on 10% SDS-PAGE. After transfer , PVDF membranes were blocked in TBS-T 
and 5% skimmed milk for 3 hours at room temperature. Membranes were then incubated 
with the primary antibody , which correspond to the specific kinase (1: 1000 dilutions) in 
primary antibody buffer (TBS-T, 5% BSA) over night at 4°C. Membranes were washed 
3 times for 5 minutes each with TBS-T and incubated with HRP-conjugated anti-rabbit 
secondary antibody ( 1 :2000 dilutions) in blocking buffer with gentle agitation for 1 hour 
at room temperature. After washing, proteins were detected using an enhanced 
chemiluminescence. 
Western blotting for IlCBa 
Equal protein contents from cell lysates were separated by 10% SDS-P AGE. After 
transfer , membranes were blocked in TBS-T supplemented with 5% skimmed milk for 
one hour at room temperature. Membranes were probed with phosphospecific IKBa 
antibody ( 1: 1000 dilutions) in TBS-T with 5% BSA, overnight at 4 °C. After washing 
membranes were incubated with HRP-conjugated secondary antibody and proteins were 
detected using an enhanced chemiluminescence as described earlier. 
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Analysis of NF-lCB Activation 
Activation of the p65 subunit of NF-KB in differentiated THP-1 cells was determined by 
means of NF-KB p65 ELISA-based transcription factor assay kits (Imgenex, San Diego, 
CA), (Hajishengallis et al., 2002; Mancuso et al., 2002). The detecting antibodie~ 
recognize epitopes on p65 that are accessible only when NF-KB is activated and bound to 
its target DNA (containing the NF-KB consensus binding site, 5'-GGGACTTTCC-3') 
attached to 96-well plates. The specificity of the assay was verified by including an 
excess of soluble oligonucleotides containing a wild type or mutated NF-KB consensus 
binding site. Extract preparation and NF-KB ELISA were carried out according to 
protocols and nuclear extraction buffer supplied by the manufacturer. Briefly, nuclear 
extracts were prepared as follows: after LPS stimulation, cells were harvested, 
centrifuged, and resuspended in hypotonic lysis buffer. After 15 minutes incubation on 
ice, 10% NP-40 was added and samples were vortexed and centrifuged. The supernatant 
was collected as the cytoplasmic extracts. Cold nuclear extraction buffer was then added 
to pellet and incubated on ice for 30 minutes, vortexing intermittently. After 
centrifugation, the supernatant was collected (nuclear extract). The NF-KB Active 
ELISA measures free p65 in the nuclear extract. The anti-p65 antibody coated plate 
captures free p65 and the amount of bound p65 is detected by adding a second anti-p65 --
antibody followed by alkaline phosphatase-conjugated secondary antibody using 
colorimetric detection in an ELISA plate reader. The optimal time of stimulation and 
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amount of total protein used m the NF-KB ELISA were determined in preliminary 
experiments. 
ELISA for TNF-a and IL-1~ 
THP-1 cells were differentiated in a 12-well tissue culture plates at a concentration of 
8 x 106 cells per well. Non-adherent cells were aspirated, and the wells were washed two 
times with PBS. After the final wash, cells were stimulated with different concentrations 
of LPS, in duplicates, and the plates were incubated for 18 hours at 37°C in a 5% CO2 
atmosphere. For blocking experiments, cells were pretreated with anti-moesin antibody 
for 2 hours prior to their LPS stimulation. The release of TNF-a and IL-1 ~ from cells 
was assayed by a commercially available Enzyme-Linked Immunosorbent Assay 
(ELISA) performed according to the manufacturer's instructions (DuoSet ELISA 
Development System R&D Systems, Minneapolis, MN). Briefly, samples and standards 
for TNF-a and IL-1~ were added to 96-well microplates coated with either anti-human 
TNF-a or IL-1 ~ capture antibody and incubated for 2 hours at room temperature. After 
washing, biotinylated anti-human TNF-a or IL-1~ was used as the detection antibody and 
streptavidin-HRP was added as the conjugate to each well. Equal proportions of 
hydrogen peroxide and tetramethylbenzidine were used as the substrate solution and the 
reaction was stopped by adding 2N sulfuric acid. All samples and standards were run in 
duplicate and optical density was determined with a Vmax microplate reader (Molecular 
Devices, Sunnyvale, CA) at 450 nm wavelength. 
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Statistical analysis. 
Data were evaluated by analysis of variance (ANOVA) and the Bonferroni multiple-
comparison test using the SPSS program (SPSS Inc. Chicago, IL). Statistical differences 
were considered significant at the level of P values of <0.05. All reported experiments 
were performed at least three times. 
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RESULTS 
Extracellular Expression and Subcellular Distribution of Moesin in differentiated 
THP-1 cells 
The expression of moesin was examined, using confocal microscopy, on differentiated 
THP-1 cells before and after LPS stimulation. Expression of moesin was observed in 
both permeabilized and non-permeabilized cells (Figure Sa and b ). Upon LPS 
stimulation, fluorescence intensity increased for both the penneabilized and the non-
permeabilized conditions (Figure Sc and d). The cell-staining pattern in permeabilized 
cells was uniform, whereas it was peripheral in the non-permeabilized cells suggesting 
expression only on the cell surface. Fluorescence intensity was observed to peak after 
one hour of LPS stimulation and the signal began to decay after 2 hours with both 
conditions (Figure 6). Control cells incubated with isotype-matched antibody showed 
weak or no fluorescence. These findings, for the first time, suggest that moesin is 
expressed on the surface of differentiated macrophage-like THP-1 cells. Expression 
increased upon LPS stimulation suggesting either a conformational change in the moesin 
molecule or recruitment of moesin to the cell surface or both. 
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Figure 5, Extracellular and Subcellular Expression of Moesin by Differentiated THP-1 
Cells using confocal microscopy 
THP-1 cells were differentiated in a chamber slide system with 20ng/ml PMA. Adherent 
cells were left unstimulated or stimulated with E. coli LPS (500ng/ml) for different times. 
Cells were either permeabilized with 0.1 % Triton-X 100 or treated with PBS and 
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incubated with moesin antibody or an Isotype-matched control antibody, labeled with 
Alexa 488 (Molecular Probes). The images were acquired with a laser scanning confocal 
microscopy (Leica Microsystems Heidelberg, Germany). The staining in non-
permeabili zed cells is preferentiall y located to the cell periphery (a and c) while in 
permeabili zed cells staining was uniform throughout the cell (band d). Following LPS 
stimulation, moesin expression increased compared to unstimulated cells in both non-
permeabili zed and permeabili zed cells. Control cells incubated with isotype-matched 
antibody showed no fluorescence in both non permeabili zed and permeabilized 
conditions (e and j) as well as resting and stimulated (g and h). 
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Control 15 minutes 30 minutes 
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Figure 6, Time Course Expressi on of Moesin on the Surface of Differentiated THP-1 
Cells. 
Differentiated THP-1 stimulated with E. coli LPS (500ng/ml) for different times (0, 5, 30, 
60 minutes, 2, and 4 hours). Cells were incubated with moesin antibody labeled with 
Alexa 488 (Molecular Probes). Following LPS stimulation , moesin expression increased 
compared to unstimulated cells. The fluorescence intensity peaked after one hour of LPS 
stimulation after which it started to decay. 
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FACS Analysis 
Flow cytometry was used to quantify moesin cell surface-expression before and after LPS 
stimulation of differentiated THP-1 cells. Figure 7a further confirms moesin expression 
on the surface of differentiated THP-1 cells. When cells were stimulated with LPS, there 
was a significant increase in the expression of moesin on the cell surface. This 
expression increased after 5 minutes of stimulation and reached the peak level after one 
hour (Figure 7b ). Similar to what was observed in the immunofluorescence staining, the 
signal intensity decreased after 2 hours of LPS incubation. (Figure 7b) 
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Figure 7, Cell Surface Expression of Moesin in Differentiated THP-1 Cells Assessed 
by FACS Analysis. 
Cells were evaluated unstimulated or stimulated with LPS (500ng/ml) for different times. 
Indirect staining with affinity purified moesin monoclonal antibody or an isotype-
matched control antibody was followed by FITC-conjugated secondary antibody. (a) The 
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broken line tracing is the isotype control, the solid line is tracing unstimulated cells with 
moesin antibody and the gray-shaded tracing is LPS stimulated-cells (one hour) with 
moesin antibody. (b) Time course from the flow cytometry analysis showed a significant 
increase in the expression of moesin on the cell surface after LPS stimulation was 
observed after one hour and consistent with the previous observation using confocal 
microscopy, the fluorescence intensity decreased significantly after 2 hours. 
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Western immunoblotting analyses of moesin total protein regulation and 
phosphorylation 
In order to investigate whether increased expression of moesin on the cell surface was an 
addition to or an increase in the total protein, and since moesin is regulated through 
conformational changes controlled by threonine phosphorylation (Bretscher et al., 2002; 
Nakamura et al., 1995; Nakamura et al., 1996), Western blotting was performed for both 
the total protein of moesin as well as the phosphorylated form. Analyses showed that 
LPS stimulation (500 ng/ml LPS) resulted in a significant time dependant increase of 
moesin total protein level (Figure 8a). The increase in the total protein mass was 
consistent with the results from the FACS analysis (Figure 8b ). Additionally, moesin 
exhibited rapid phosphorylation after only 15 seconds of LPS stimulation (Figure 9a). 
This was followed by a significant dephosphorylation after 5 minutes (Figure 9b ). 
Surprisingly, another peak of phosphorylation state was observed at 30 minutes that again 
was followed by dephosphorylation at 60 minutes (Figure 9b ). These results suggest that 
moesin is an active molecule and its responds to LPS is rapid. 
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Figure 8, Western Blotting for Moesin Total Protein after LPS Stimulation. 
Western blotting analysis of total protein showed that when cells were stimulated with 
LPS there was a significant up regulation of the total protein mass of moesin. This up 
regulation was in a time dependant manner reaching a peak at 60 minutes. 
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Figure 9, Analysis of Moesin Phosphorylation Upon LPS Stimulation. 
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When study ing the phosphorylated form moesin, in differentiated THP-1 cells, there was _ 
a rapid increase in the phosphorylation after 15 seconds of LP S stimulation. This was 
followed by dephosphorylation and another phosphorylation which was more significant 
than the earlier event at 30 minutes that was followed by dephosphorylation. Figure 9b 
represents the data expressed as a ratio of p-moesin to total moesin. 
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Quantitative Real-time RT-PCR analysis 
Since there was an increase in the total protein mass of moesin after LPS stimulation, we 
thought to investigate moesin mRNA levels after LPS challenge. Quantitative RT-PCR 
showed that there was a significant increase in the mRNA level of moesin at 90 minutes 
after LPS stimulation. (Figure 10). 
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Figure 10, Real-Time Reverse Transcription Polymerase Chain Reaction (Real-time 
RT-PCR). 
Real-time RT-PCR was used to study mRNA levels of moesin after LPS stimulation. The 
results showed that there was an increase in the levels of mRNA after LPS stimulation. 
The increase was significant after 60, 90 and 120 minutes (p<0. 05). 
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Immunoprecipitation 
To evaluate the participation of moesm m propagating the LPS signal, 
immunoprecipitation with anti-moesin antibody was performed. TLR4 and MD-2 were 
demonstrated to co-immunoprecipitate with moesin when the cells were stimulated with 
LPS (Figure 11). On the other hand , CD14 was found to be co-immunoprecipitated with 
moesin constantly. Immunoprecipitation with antibody to radixin failed to reveal any 
specific bands . 
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Figure 11, Immunoprecipitation and Western Blotting Analyses 
Cell lysates from resting and treated samples were immunoprecipitated with moesin 
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antibody followed by Western blotting using antibodies against CDI 4, TLR4 and MD-2. 
An equal volume from each sample was separated by SDS-PAGE, prior to 
immunoprecipitation, and Western blotting was performed for /3-actin as a control for 
equal loading. The results showed that CDI 4 co-immunoprecipitated with moesin in both 
the resting and stimulated conditions, with a stronger signal in the stimulated condition. 
There was no association observed between TLR4 or MD-2 and moesin in the resting cell 
lysates. After 5 minutes of stimulation, both TLR4 and MD-2 were observed co-
immunoprecipitated with moesin. 
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Recruitment of IRAK to MyD88 and Phosphorylation and Subsequent Activation of 
TRAF6 
Since it essential for MyD88 to recruit IRAK, we investigated the inhibition of this 
interaction in cells treated with anti-moesin antibody. As shown in Figure 12a, anti-
moesin antibody inhibited the association of IRAK with MyD88. Upon activation , IRAK 
phosphorylates at threonine 100· Cells stimulated with LPS exhibited phosphorylation of 
IRAK (Figure 12b). When the cells were pre-incubated with moesin antibody , there was 
total inhibition of IRAK phosphorylation (Figure 12c). Moreover, for proximal signals 
to transducer , IRAK needs to bind activate TRAF6 which plays a central role in LPS 
mediated signaling. lmmunoprecipitation with IRAK antibody followed by W estem 
blotting for TRAF6 was performed. Cells pretreated with anti-moesin antibody showed 
inhibition of the binding of IRAK to TRAF6 when compared to the resting conditions. 
(Figure 12c). No inhibition was observed when the cells were incubated with an isotype-
matched control lgG. These results demonstrate that when moesin was blocked the LPS 
signaling cascade was also blocked. 
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Figure 12, Inhibition of the Recruitment of /RAK to MyD88 and /RAK Activation and 
Phosphorylation by Anti-Moesin Antibody. 
Upon LPS activation, /RAK is recruited by MyD88 to the receptor complex, 
phosphorylated and subsequently bound to TRAF6 which relays the signal downstream. 
Stimulated differentiated THP-1 cells, with and without prior treatment with anti-moesin 
antibody or an isotype-matched control antibody, were lysed (as described in the 
Materials and Methods) and subjected to immunoprecipitation with either MyD88 goat 
lgG followed by Western blotting for /RAK (Figure 12a) or immunoprecipitated with 
/RAK rabbit lgG followed by Western Blot with an antibody that recognizes threonine 
phosphorylation or TRAF6 (Figure 12 b and c, respectively). The results showed that 
when cells were pre-treated with anti-moesin antibody, recruitment of /RAK to MyD88 
was inhibited and subsequent /RAK phosphorylation was blocked (Figure 12 a and b, 
respectively). Furthermore, /RAK binding to TRAF6 was also inhibited. (Figure 12c). No 
effects were observed when the differentiated THP-1 cells were pre-incubated with the 
isoype-matched control antibody prior to LPS stimulation. 
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p38 and p44/42MAP Kinase Activity analysis 
In order to determine which signaling cascade is being inhibited by anti-moesin antibody, 
the activation and phosphorylation of p44/42 and p39 MAPK in response to LPS were 
analyzed. The results showed that both p38 as well as p44 /42 MAPK were activated and 
reached their maximal phosphorylation at 30 minutes (Figure 13a and 14a). When cells 
were preincubated with moesin antibody prior to LPS challenges , no phosphorylation of 
either MAP kinases was detected (Figure 13b and 14b ), suggesting further the essential 
role of moesin in transducing upstream signals. 
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Figure 13, Effect of Anti-moesin Antibody on p38 MAPK Activity 
Normal p38 activation by LPS (500ng/ml) was first analyzed and maximum activation for 
both was observed at 30 minutes (Figure 13a). Differentiated THP-1 cells were not 
pretreated or were pretreated with anti-moesin antibody (1 0µglml), isotype-matched 
control antibody (J0µglml) or p38 inhibitor SB202190 (25µM). Cell pretreated with anti-
moesin antibody or SB202190 prior to LPS stimulation showed significantly less p38 
activation (Figure 13b and c). 
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Figure 14, Effect of Anti-moesin Antibody on p44/42 MAPK Activity 
Normal p44 /42 activation by LPS (500ng/ml) was first analyz ed and maximum activation 
for both was observed at 30 minutes (Figure 14a). For blocking experiments, 
differentiated THP-1 cells were pretreated with anti-moesin antibody (1 0µglml), isotype-
matched control antibody (J0µglml) or p44/42 inhibitor PD98059 (25µM). Cell 
pretreated with anti-moesin antibody or PD98059 prior to LPS stimulation showed 
significantly less p44/42 activation (Figure 14b and c). 
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IKBcx phosphorylation and NF-KB activation 
NF-KB is nonnally inactive by physical interaction with Ild3a. Upon activation , IKBa 
phosphorylates , ubiquitinate and degrades allowing NF-ld3 factors to translocate to the 
nucleus and exert their trans-activation function. NF-KB p65 ELISA-based transcription 
factor assay kits was used (Imgenex, San Diego , CA) (Hajishengallis et al., 2002; 
Mancuso et al., 2002). The detecting antibodies recognize epitopes on p65 that are 
accessible only when NF-KB is activated and bound to its target DNA (containing the 
NF-KB consensus binding site, 5'-GGGACTTTCC-3'). The specificity of the assay was 
verified by including an excess of soluble oligonucleotides containing a wild type or 
mutated NF-ld3 consensus binding site. Differentiated THP-1 cells were stimulated with 
LPS with or without preincubation with anti-moesin antibody ( 1 0µg/ml) or an isotype-
matched control IgG. Cells were then harvested and resuspended in hypotonic lysis 
buffer. After adding 10% NP-40 samples were vortexed and centrifuged. The 
supernatant was collected as the cytoplasmic extracts which was used in W estem blotting 
assays for the phosphoiylated form of Ild3a. Cold nuclear extraction buffer was then 
added to pellet, vortexing intermittently. After centrifugation, the supernatant was 
collected (nuclear extract). The NF-ld3 Active ELISA measures free p65 in the nuclear 
extract. The anti-p65 antibody coated plate captures free p65 and the amount of bound 
p65 is detected by adding a second anti-p65 antibody followed by alkaline phosphatase-
conjugated secondary antibody using colorimetric detection in an ELISA plate reader . 
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We found that upon LPS challenge IKBa phosphorylation and was followed by the 
translocation and activation of the NF-KB dimers (Figure 14a and b ). No 
phosphorylation of IKBa was detected when the cells were treated with anti-moesin 
antibody prior to LPS stimulation. Moreover, NF-KB activity was significantly inhibited. 
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Figure 15, 11dJaPhosphorylation and NF-ldJ translocation and activation. 
Differentiated THP-1 cells were stimulated with LPS (500ng/ml). For blocking 
experiments, cells were treated with anti-moesin antibody (1 Oµglml) prior to LPS 
stimulation. Cytoplasmic and nuclear extraction was performed according to the 
manufacturer recommendations (Imgenex, San Diego, CA). Western blotting for the 
phosphorylated form of IKB a was performed. NF-Ki3 translocation and activation was 
measured using the active ELISA assay. a) Phosphorylation of IKB a when the cells were 
stimulated with LPS. No phosphorylation was observed in cells pretreated with anti-
moesin antibody. b) Translocation and activation of NF-KB to the nucleus upon LPS 
stimulation. When cells were pretreated with anti-moesin antibody, no translocation was 
observed, further confirming the previous findings. Preincubation with an isotype-
matched control. No effects were observed when the differentiated THP-1 cells were pre-
incubated with an isotype-matched control IgG. 
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ELISA for TNFcx and IL-1~ secretion 
Finally, ELISA was used to assess the TNF-a and IL-I~ secretion by the differentiated 
THP-I cells. Results revealed a significant reduction in TNF-a as well as IL-I~ 
secretion when cell were preincubated with moesin antibody prior to LPS stimulation. 
(ANOV A with Bonferroni correction for multiple comparisons, p<0.05), whereas cell 
preincubated with an isotype-matched control IgG showed no change (Figure 16a and b ). 
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Figure 16, EffectofMoesin on TNFaand IL-lf3Secretion in LPS Stimulated Cells 
Cells were cultured as described in "Materials and Methods" and were not pretreated or 
pretreated with anii-moesin antibody or an isotype-matched control (1 Oµglml) followed 
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by LPS stimulation (10, 100, and 1000 ng/ml) for 18 hours. The media was collected and 
subjected to ELISA measuring the TNF-a and IL-1/3 concentration. Absorbance was 
measured at 45 0 nm wavelength and concentration inferred from a standard curve. Data 
is presented as average mean for 3 experiments with standard deviation and analyzed by 
ANOVA with Bonferroni correction for multiple comparisons. Consistent with previous 
reports, there was a significant inhibition of the production of TNF a and IL-1 /3 in cells 
pretreated with anti-moesin antibody (p<0.05). 
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DISCUSSION 
The current understanding of the innate recognition of bacterial LPS is based on the 
discovery that LPS binds to the LPS-binding protein (LBP) in serum (Schumann et al., 
1990) which, in turn, rapidly catalyzes the transfer of LPS to membrane-bound CD 14 
(mCD14) or soluble CD14 (sCD14). Although CD14 has been identified as an LPS 
receptor (Wright et al., 1990), it is a glycosylphosphatidylinositol (GPI)-anchored protein 
and thus, lacks transmembrane and intracellular domains (Haziot et al., 1988; Van 
Amersfoort et al., 2003). The mechanism by which CD14 mediates a transmembrane 
signal has remained elusive. It was suggested that additional transmembrane receptors 
must act in concert with LPS-CD 14 complex to initiate the signaling process leading to 
LPS-induced cellular activation. A theory which was strengthened by several binding 
studies showed that CD 14-blocking monoclonal antibodies could only partially inhibit 
LPS-binding, suggesting the existence of alternative receptors (Blondin et al., 1997; Lynn 
et al., 1993; Triantafilou et al., 2000; Troelstra et al., 1997). Over the last decade, 
extensive work on the innate recognition of LPS has focused on identifying the putative 
transmembrane molecule that acts as an LPS-signal transducer. Attempts to discover 
molecules that bind LPS directly identified several receptors (Dziarski, 1991; El-
Samalouti et al., 1997; Kirkland et al., 1990; Lei and Morrison, 1988; Triantafilou et al., 
2001). Using mostly genetic approaches as well as transfection methods, the human 
counterpart of Drosophila toll receptors revealed that TLR4 is the main toll-like molecule 
involved in LPS signaling (Arbour et al., 2000; Hoshino et al., 1999; Lien et al., 2000; 
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Takeuchi et al., 1999; Van Amersfoort et al., 2003). This was also confirmed by 
identifying the Lps gene responsible for the failure of LPS to induce pro-inflammatory 
responses in C3H/HeJ and C57BL/10ScCr mouse strains using positional cloning 
(Poltorak et al., 1998a; Qureshi et al., 1999). TLR4 knockout mice demonstrated the 
importance of the TLR4 in LPS signaling (Hoshino et al., 1999). In addition, TLR4 
mutations conferred a role for this molecule in humans (Schwartz, 2001 ). 
TLR4, possessing the TIR domain, in the cytoplasmic portion, is considered essential for 
triggering activation of the LPS-induced activation of MAPKs and the transcriptional 
factor NF-KB (Akira et al., 2001; Means et al., 2000; Sato et al., 2002). However, no 
substantial data provides evidence on whether LPS actually interacts directly with TLR4. 
Only in the presence of CD14, using 1251-labeled LPS probe, it was demonstrated that 
TLR2 and TLR4 were labeled, however, one can argue that crosslinking modifiers 
indicate that only the photoaffinity crosslinking probe and the molecule were in sufficient 
close proximity to permit such covalent interaction (da Silva Correia et al., 2001). 
Moreover, when studying the association of TLR4 to CD14, Jiang et al. (Jiang et al., 
2000) showed that LPS stimulation promoted significant physical proximity between 
CD 14 and TLR4 suggesting a close interaction but not binding. Furthermore, the 
response of TLR to LPS is strongly dependent on CD 14 and LBP (Muta and Takeshige, 
2001). 
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Recently, Shimazu et al. (1999) showed that TLR4 requires an additional molecule, MD-
2, which forms a complex with the extracellular domain of TLR4, for effective LPS 
recognition (Shimazu et al., 1999). They found that in vitro transfection of TLR4 cDNA 
did not confer LPS responsiveness on the HEK-293 cell line and a mouse IL-3-dependent 
pro-B cell line Ba/F3 (Shimazu et al., 1999). Unresponsiveness of LPS to the TLR4-
expressing cells was subsequently explained by another LPS recognition molecule, MD-2 
(Miyake et al., 1995; Miyake et al., 1998). Physical association of MD-2 with TLR4 is 
critical for LPS responses (Miyake, 2004 ). A variety of in vitro studies demonstrated that 
LPS hyporesponsiveness in cells expressing TLR4 alone or TLR4 with mutant MD-2 was 
rescued and increased by the transfection of MD-2 cDNA or soluble MD-2 protein (da 
Silva Correia et al., 2001; Ohnishi et al., 2003; Schromm et al., 2001; Shimazu et al., 
1999; Visintin et al., 2001 ). Furthermore, mice lacking MD-2 did not respond to LPS, 
survived experimentally induced endotoxin shock (Nagai et al., 2002). It was also 
demonstrated that LPS did bind directly to MD-2 without LBP participation and it is 
physically associated with TLR4 and MD-2 in the presence of CD14 (da Silva Correia et 
al., 2001). Even though, TLR4 and MD-2 are now currently accepted to be required for 
LPS signal transduction (Beutler, 2000; Shimazu et al., 1999), no definitive mechanisms 
were identified how does TLR4 interact with CD14-LPS to transduce the signal and no 
high-affinity binding of LPS to TLR4 has been demonstrated. 
Previously, using crosslinking to investigate LPS membrane interactions, our group has 
found that LPS binds to two proteins; the well-established receptor for LPS, CD 14, and a 
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novel LPS binding molecule identified as moesin (Tohme et al., 1999). Experiments, 
using antibody to moesin, abrogated TNF-a production at all LPS concentrations tested 
(Tohme et al., 1999). In addition, the inhibition was specific for the LPS-moesin 
interaction, since unrelated receptor ( fMLP and IL-1) mediated events were not inhibited 
by anti-moesin IgG. The response to the gram-positive bacterium S. aureus was also not 
abrogated by moesin antibody confirming that the effects were unique to LPS elicited 
responses (Tohme et al., 1999). Conversely, CD14 antibodies were able to completely 
abrogate the TNF response only at lower concentration of LPS. The observation that at 
lower concentrations CD 14 antibody partially reduced binding of LPS to moesin suggests 
that these two receptors (CD14 and moesin) may physically interact for optimal binding 
of LPS and transduction of the signal (Tohme et al., 1999). Therefore, elucidating the 
means of activation and aggregation of CD14-moesin-TLR4-MD2 and their specific role 
in the innate immune response is important for understanding how the host protects itself 
from the invading microbes. 
In the present study, we have provided characterization of the cell surface expression of 
moesin after exposure to LPS and subsequent moesin mediated intracellular signaling in 
macrophage-like differentiated THP-1 cells. Data from confocal immunofluorescence 
analyses showed, for the first time that, moesin is expressed on the surface. Another 
novel finding was that stimulation with LPS resulted in a significant increase of moesin 
expression. This was further confirmed by F ACS analysis where the expression of 
moesin on the cell surface was found to increase approximately 1. 7 fold upon LPS 
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challenge. LPS also caused a significant increase in moesin protein level, when 
measured by Western blotting, implying possible up-regulation of moesin mRNA m 
response to LPS. Therefore, real-time RT-PCR was performed. Moesin mRNA was 
found to increase significantly (2-fold) upon LPS stimulation. Furthermore, increased 
expression on the surface suggested either a conformational change in the moesin 
molecule or recruitment of moesin to the cell surface or both. To study this phenomenon, 
Western blotting for the phosphorylated form of moesin was performed. Moesin was 
observed to go through different stages of rapid phosphorylation and dephosphorylation, 
which is indicative that this protein is highly active in response to LPS. The moesin 
surface expression is similar to reported increase expression of CD 14 upon LPS 
stimulation (Landmann et al., 1991; Quentmeier et al., 1996; Rodeberg et al., 1997). On 
the other hand, TLR4/MD-2 surface expression decrease after LPS stimulation (Akashi et 
al., 2000; Nomura et al., 2000). This decrease in expression was attributed to either 
disruption of the TLR4 and MD-2 association or internalization of these molecules. 
We have also established that moesin is associated with CD 14 as well as TLR4 and MD-
2 in immunoprecipitation experiments. It is interesting to note that the association of 
moesin to CD 14 was independent from LPS stimulation while the association of moesin 
to TLR4 and MD-2 was LPS-dependent. Previous reports demonstrated that CD14 is an 
essential molecule for LPS recognition and bringing LPS to close proximity to TLR4 ( da 
Silva Correia et al., 2001; Jiang et al., 2000; Muta and Takeshige, 2001). The findings in 
the present study provided evidence that CD 14/moesin complex could be essential to the 
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association of LPS to TLR4/MD-2. Finally, we were also able to show that moesin is 
critical in LPS-induced proximal intracellular signals. When moesin was blocked using 
specific anti-moesin antibody, LPS intermediate signaling components, including 
MyD88, IRAK and TRAF6 were blocked. Moreover , activation of the MAP kinases 
ERK and p38, an important mediators in cellular responses to LPS (Defranco et al., 
1998) and lld3a phosphorylation and NF-KB activation and translocation to the nucleus 
(Ghosh et al., 1998) was inhibited, and this inhibition led to blocking of subsequent TNF-
a and IL-1~ production. 
The human gene encoding moesin was cloned (Lankes and Furthmayr, 1991), and its 
sequence was shown to contain neither a signal peptide nor transmembrane domain 
suggesting that the protein is not integrally incorporated into the plasma membrane 
making it available for free movement upon activation and phosphorylation (Ivetic and 
Ridley, 2004; Nakamura et al., 1995; Nakamura et al., 1996). This was evident in our 
results where moesin was found to be a very dynamic molecule with the apparent 
capability of quick activation (phosphorylation) and relocation upon LPS stimulation. 
Several studies have proposed a role for moesin as a receptor since it is expressed on the 
cell surface. Keresztes et al. suggested (Keresztes et al., 1998) that upon adhesion of 
porcine neutrophils to a plastic surface, moesin is translocated to the plasma membrane 
and the extracellular surface. Ariel et al. (Ariel et al., 2001) implied that moesin could be 
expressed on the cell surface not only by stimulation with PHA or PMA but also by 
calyculin A, a specific inhibitor of phosphatases 1 and 2A, capable of inducing moesin 
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phosphorylation (Nakamura et al., 1996). Previous reports (Paglini et al., 1998; 
Takeuchi et al., 1994) revealed that inhibiting moesin gene expression was difficult, 
which led us to use two different antisense oligonucleotides (Paglini et al., 1998) in a 
recent work from our group to specifically knock-down moesin gene expression m 
macrophage-like differentiated THP-1 cells (Iontcheva et al., 2004). The results 
demonstrated that it took at least 48 hours of antisense oligonucleotide cell treatment, i.e. 
fresh oligonucleotide added every four hours, in order to accomplish complete inhibition 
of the moesin gene (Iontcheva et al., 2004). This was confirmed by Western blotting data 
showing that moesin was completely suppressed and that lasted 48 hours. Moreover, 
when moesin knockdown cells were stimulated with LPS, there was 82% decrease in the 
production ofTNF-a compared to control cells (Iontcheva et al., 2004). 
The diversity of moesin as a biological molecule is readily visualized by its rich structural 
domain presentation and capability of numerous different interactions with other proteins. 
At its N-terminus, moesin and other proteins from this family have a so-called FERM 
(band four-point-one , ~zrin, radixin, moesin homology domain) containing sequences of 
three subdomains Fl-F3 (Finnerty et al., 2004; Pearson et al., 2000). Fl has similarity to 
ubiquitin (Vijay-Kumar et al., 1987), F2 has similarity to acyl-CoA binding protein 
(Kragelund et al., 1993) and F3 has similarity to PTB (phosphotyrosine-binding module), 
PH (pleckstrin homology domain) and VHl (Enabled/V ASP Homology 1) (Forman-Kay 
and Pawson, 1999). The cluster of acidic amino acids, especially in the PH homology 
domain, has been shown to be important in interactions of ERM proteins with lipid layers 
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of the membrane (Niggli, 2001 ). Although moesin lacks a membrane-spanning domain, 
crystallographic studies recently showed that these proteins are able to interact and link 
with various lipid fractions in the membrane (Edwards and Keep, 2001; Finnerty et al., 
2004; Sechi and Wehland, 2000; Simons et al., 1998). As a structural protein, moesin 
plays role as a cellular stabilizer together with ezrin and radixin, linking cellular actin 
cytoskeleton to the membrane and thus participating in numerous events connected with 
cell shape changing from establishing cell contacts and adhesion to signal transduction 
(Gautreau et al., 2002). Moesin has been characterized as an essential protein for the 
formation of focal adhesions in response to active Rho in permeabilized fibroblasts 
(lvetic and Ridley, 2004; Mackay et al., 1997). There is also increasing evidence for 
involvement of moesin as a key molecule in adhesion events during the inflammation 
process in different types of cells (Masumoto et al., 1998). Recently, it has been shown 
that moesin interacts with vascular adhesion molecule (VCAM-1) during leukocyte 
adhesion and transendothelial migration (Barreiro et al., 2002). The role of moesin in 
inflammation has been confirmed in studies showing binding of N-terminal moesin in 
PMA stimulated lymphocytes to the cytoplasmic tail of L-selectin, and this binding to be 
regulated by protein kinase C (lvetic et al., 2002; lvetic et al., 2004). In addition, moesin 
has been implicated in the regulation ofT cell adhesion and has been shown to be present 
as a receptor expressed on the surface of T cells (Ariel et al., 2001). It was shown in the 
same study that moesin is involved in binding IL-2 peptides and subsequent adhesion of 
activated T cells to extracellular matrix. Finally, moesin homozygote knockout mice 
were found to exhibit a 3-fold reduction in LPS-induced inflammation after subcutaneous 
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LPS injection suggesting a role for moesin in the LPS-induced inflammatory response 
(Amar et al., 2001). Recent experiments with antisense approach showed the 
involvement of moesin protein in receptor/signal transduction events (Iontcheva et al., 
2004). These data extend our previous observations made in knockout mice (Amar et al., 
2001) and further support a role of moesin in LPS recognition and subsequent 
intracellular signaling. The current work is the first study that showed the expression of 
moesin on the cell surface, increased expression upon LPS challenge, and association of 
moesin with CD 14, TLR4, and MD-2 proteins. Immunoprecipitation with moesin 
antibody revealed presence of CD 14, TLR4, and MD-2, the established LPS receptor 
molecules. The current work demonstrates that moesin binds to CD 14 in both the resting 
and stimulated condition which is consistent with previous cross linking experiments 
(Tohme et al., 1999). Moreover, moesin was also associated with TLR4 and MD-2, 
implicating a role for moesin in the formation of the protein receptor complex. Moesin 
may be solely involved in the formation of the receptor complex, or it may have function 
as an independent receptor, since it has been shown to bind directly to LPS (Tohme et al., 
1999). 
Since TLR4 is tightly connected to the innate immunity, but never been isolated as an 
LPS-receptor, the association of moesin with TLR4 reveals a new mechanism and 
illustrates additional diversity and redundancy in the biological activity of these two 
proteins. Our new finding on physical association between moesin and CD 14, TLR4 and 
MD-2 emphasizes the functional importance of moesin in the activation of the receptor 
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cluster. Furthermore, the data suggest that the main function of moesin is to transfer LPS 
to TLR4/MD-2. We also report direct visualization of moesin on the cell surface by 
fluorescent antibody techniques. Expression of moesin was upregulated by LPS 
challenge. Based on our understanding of the folding of the FERM domain of moesin, 
and moesin not having a transmembrane domain, it would appear that moesin resides on 
the cell folded upon itself in its inactive form. LPS binds and activates this protein by 
phosphorylation exposing its binding domains and allowing it to bind to TLR4 and MD-
2. This is evident as dephosphorylation of moesin which masks the binding site of 
moesin, suggesting the binding ofmoesin to TLR and MD-2 (Figure 11). 
Based on our previous and current results, accumulating evidence points towards a new 
model where CD 14 and TLR4 are not solely responsible for LPS recognition. Thus, we 
propose a model (Figure 17) in which LPS initially binds to CD 14/moesin complex. 
Moesin then undergoes phosphorylation (unfolding). This complex then forms a cluster 
with TLR4/MD-2. This suggestion is based on the dephosphorylation state of moesin, 
which occurred after approximately 5 minutes of LPS challenge, as the binding to 
TLR4/MD-2 obscures the binding domain of moesin. The Western 
blotting/immunoprecipitation results support this concept. Moreover, this finding also 
suggests that moesin could be the LPS-presenting protein to the TLR4/MD-2. This big 
cluster of molecules then recruits !RAK through the adaptor protein MyD88. IRAK then 
phosphorylates and dissociates from MyD88 and bind to TRAF6. TRAF6, being a 
central molecule in LPS-mediated signaling, phosphorylates IKK and MAPK. These 
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kinases in tum phosphorylates down stream kinases leading to the activation of NF-KB as 
well as p38 and p44/42, among others. The transcription and secretion of 
proinflammatory cytokines ( e.g. TNF-a) then occurs. 
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Figure 17. Proposed Model for the Recognition in LPS. 
In the absence of stimulation, CD14 and moesin seems to be bound together. Following 
LPS stimulation, CD14/moesin recognizes LPS and there is increase aggregation of 
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moesin as well as CD 14 on the cell surface. Moes in phosphorylation is significantly 
increased at that point allowing it to unfold and bind to the TLR4/MD-2 molecules. This 
cluster of receptors then activates the adaptor protein MyD88. MyD88 recruits and 
activates !RAK through their prospective death domains. !RAK subsequently auto-
phosphorylates and dissociates from MyD88 and interacts with TRAF6. 
Active TRAF6 then activates and phosphorylates IKK which in turn phosphorylate Jl([Ja 
The phosphorylation of Jl([Ja results in its degredation and freeing NF-l([J. NF-l([J 
translocate to the nucleus where it can begin transcription. Another cascade is the MAP 
Kinase pathway. TARF6 activate. These kinases phosphorylate MKK.3/6, MKK.4, MEK 
and NIK. NIK is another activator of IKK. TAB 1, 2 and TAKI are activators of p38, 
JNK and ERK 1/2 (p44/42). The activation of these MAPK leads to the production of 
pro-inflammatory cytokines, namely TNF a 
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Because CD 14 and moesin are found in micro-domains , it is possible that the entire 
bacterial recognition system is based on the ligation of CD 14 and moesin by bacterial 
products and the formation of a signaling complex of receptors at the site of CD 14-
moesin-LPS ligation within membrane micro-domains. Since different receptors are 
recruited to the site of ligation forming an activation cluster , multiple signaling cascades 
are triggered. Thus, the existence of a receptor cluster explains the variety of signaling 
cascades that are triggered by LPS. LPS has been shown to be able to activate the NF-
KB, ERK.1/2 (p44/42) and p38 pathways. It is possible that different cell types and 
different supramolecular complexes utilize different intracellular pathways. The 
existence of a receptor cluster responsible for bacterial recognition could explain why the 
search for anti-sepsis therapies has been so elusive. Therapeutic interventions targeting 
single components of this complex could be unsuccessful. Therefore, future therapeutic 
approaches targeting multiple receptors should be considered. 
In conclusion, the activation of moesin in macrophages is highly dynamic and appears to 
be regulated positively by LPS. It is our view that based on the lack of compelling 
binding data; TLR4 might well be downstream of the initial step of LPS recognition. 
LPS binds first to moesin and CD14 and TLR4 is recruited later. Therefore, we propose 
that the innate recognition of LPS involves the dynamic association of multiple receptors 
forming a cluster of molecules. In order to better understand how and where moesin is 
activated, identifying the kinase( s) and phosphatase( s) responsible for moesin regulation 
in vivo should be a major goal for future research. In addition, the physiological 
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relevance of C-terminal phosphorylation (T558) remains to be clarified. It is possible that 
moesin has several stages of activation and that the ability to bind proteins may rely on 
how many critical activation residues are phosphorylated. What also needs to be 
determined is where moesin binds to CD14, TLR and MD-2. Finally, the analysis of 
macrophages lacking functional moesin proteins should provide further insight into inter-
relationship and physiological functions. 
106 
BIBLIOGRAPHY 
Aderem A, Ulevitch RJ (2000) .. Toll-like receptors in the induction of the innate immune 
response. Nature 406( 6797):782- 7. 
Aird WC (2003a). The hematologic system as a marker of organ dysfunction in sepsis. 
Mayo Clin Proc 78(7):869-81. 
Aird WC (2003b ). The role of the endothelium in severe sepsis and multiple organ 
dysfunction syndrome. Blood 101(10):3765-77. 
Ajizian SJ, English BK, Meals EA (1999). Specific inhibitors of p38 and extracellular 
signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric 
oxide synthase and tumor necrosis factor accumulation in murine macrophages 
stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179(4):939-44. 
Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, Miyake K (2000). 
Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like 
receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164(7):3471-5. 
Akira S, Takeda K, Kaisho T (2001). Toll-like receptors: critical proteins linking innate 
and acquired immunity. Nat Immunol 2(8):675-80. 
Amar S, Oyaisu K, Li L, Van Dyke T (2001 ). Moesin: a potential LPS receptor on human 
monocytes. J Endotoxin Res 7(4):281-6. 
107 
Amieva MR, Furthmayr H (1995). Subcellular localization ofmoesin in dynamic 
filopodia , retraction fibers, and other structures involved in substrate exploration, 
attachment , and cell-cell contacts . Exp Cell Res 219( 1 ): 180-96. 
Anderson KV (2000). Toll signaling pathways in the innate immune response. Curr Opin 
lmmunol l2(l):l3-9. 
Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, Monaco C, 
Feldmann M, Foxwell BM (2004). Distinct pathways ofLPS-induced NF-kappa B 
activation and cytokine production in human myeloid and nonmyeloid cells defined by 
selective utilization ofMyD88 and MaVTIRAP. Blood 103(6):2229-37. 
Andrews T, Sullivan KE (2003). Infections in patients with inherited defects in 
phagocytic function. Clin Microbiol Rev 16(4):597-621. 
Annema A, Sluiter W, van Furth R (1992). Effect of interleukin 1, macrophage colony-
stimulating factor , and factor increasing monocytopoiesis on the production of leukocytes 
in mice. Exp Hematol 20(1):69-74. 
Anrather J, Csizmadia V, Soares MP, Winkler H (1999). Regulation ofNF-kappaB RelA 
phosphorylation and transcriptional activity by p21 (ras) and protein kinase Czeta in 
primacy endothelial cells. J Biol Chem 274(19):13594-603. 
Arbour NC, Lorenz E, Schutte BC, Zahner J, Kline JN, Jones M, Frees K, Watt JL, 
Schwartz DA (2000). TLR4 mutations are associated with endotoxin hyporesponsiveness 
in humans. Nat Genet 25(2):187-91 . 
Arend WP, Dayer JM (1995). Inhibition of the production and effects of interleukin-I 
and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 38(2): 151-60. 
108 
Arend WP, Malyak M, Guthridge CJ, Gabay C (1998). Interleukin-I receptor antagonist: 
role in biology. Annu Rev lmmunol 16(27-55. 
Ariel A, Hershkoviz R, Altbaum-W eiss I, Ganor S, Lider O (2001 ). Cell surface-
expressed moesin-like receptor regulates T cell interactions with tissue components and 
binds an adhesion-modulating IL-2 peptide generated by elastase. J lmmunol 
166(5):3052-60. 
Asai Y, Hashimoto M, Ogawa T (2003). Treponemal glycoconjugate inhibits Toll-like 
receptor ligand-induced cell activation by blocking LPS-binding protein and CD 14 
functions. Eur J lmmunol 33(11 ):3196-204. 
Aschoff L (1924). Das reticulo-endothelial system. Ergeb. Inn. Med. Kinderheilkd 26(1-
118. 
Barreiro 0, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor 
R, Furthmayr H, Sanchez-Madrid F (2002). Dynamic interaction ofVCAM-1 and ICAM-
1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. 
J Cell Biol 157(7): 1233-45. 
Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, Goldfeld 
AE (2003). Regulation of tumor necrosis factor alpha gene expression by mycobacteria 
involves the assembly of a unique enhanceosome dependent on the coactivator proteins 
CBP!p300. Mo/ Cell Biol 23(2):526-33. 
Batchelor CL, Woodward AM, Crouch DH (2004). Nuclear ERM (ezrin, radixin, moesin) 
proteins: regulation by cell density and nuclear import. Exp Cell Res 296(2):208-22. 
109 
Bazil V, Strominger JL ( 1991 ). Shedding as a mechanism of down-modulation of CD 14 
on stimulated human monocytes. J Immuno/ 147(5):1567-74. 
Beg AA, Sha WC , Bronson RT, Ghosh S, Baltimore D (1995). Embryonic lethality and 
liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 
376(6536): 167-70. 
Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R (1998). IkappaBalpha 
degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-
I beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. 
Requirement for an additional activation pathway. J Biol Chem 273(12):6607-10. 
Berryman M, Franck Z, Bretscher A (1993). Ezrin is concentrated in the apical microvilli 
of a wide variety of epithelial cells whereas moesin is found primarily in endothelial 
cells. J Cell Sci 105 ( Pt 4)(1025-43. 
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986). Control of cachectin 
(tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 
232( 4753):977-80. 
Beutler B (2000). Endotoxin, toll-like receptor 4, and the afferent limb of innate 
immunity. Curr Opin Microbiol 3(1):23-8. 
Beutler B (2001 ). Sepsis begins at the interface of pathogen and host. Biochem Soc Trans 
29(Pt 6):853-9. 
Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, 
Fiers W (1996). The p38/RK mitogen-activated protein kinase pathway regulates 
interleukin-6 synthesis response to tumor necrosis factor. Embo J 15(8):1914-23. 
110 
Blondin C, Le Dur A, Cholley B, Caroff M, Haeffner-Cavaillon N ( 1997). 
Lipopolysaccharide complexed with soluble CD 14 binds to nonnal human monocytes. 
Eur J lmmunol 27(12):3303-9. 
Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72(248-
54. 
Bretscher A, Reczek D, Berryman M (1997). Ezrin: a protein requiring conformational 
activation to link microfilaments to the plasma membrane in the assembly of cell surface 
structures. J Cell Sci 110 ( Pt 24)(3011-8. 
Bretscher A (1999). Regulation of cortical structure by the ezrin-radixin-moesin protein 
family. Curr Opin Cell Biol l l(l):109-16. 
Bretscher A, Chambers D, Nguyen R, Reczek D (2000). ERM-Merlin and EBPS0 protein 
families in plasma membrane organization and function. Annu Rev Cell Dev Biol 16(113-
43. 
Bretscher A, Edwards K, Fehon RG (2002). ERM proteins and merlin: integrators at the 
cell cortex. Nat Rev Mo/ Cell Biol 3(8):586-99. 
Bull P, Morley KL, Hoekstra MF, Hunter T, Verma IM (1990). The mouse c-rel protein 
has an N-terminal regulatory domain and a C-terminal transcriptional transactivation 
domain. Mo/ Cell Biol 10(10):5473-85. 
111 
Burger D, Dayer JM (2002). Cytokines, acute-phase proteins, and hormones: IL-1 and 
TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. 
Ann N YA cad Sci 966( 464- 73. 
Burke B, Lewis CE (2002). The macrophage. 2nd ed. Oxford; New York: Oxford 
University Press. 
Cao Z, Henzel WJ, Gao X (1996). IRAK: a kinase associated with the interleukin-I 
receptor. Science 271 (5252): 1128-31. 
Carter AB, Knudtson KL, Monick MM, Hunninghake GW (1999a). The p38 mitogen-
activated protein kinase is required for NF-kappaB-dependent gene expression. The role 
of TATA-binding protein (TBP). J Biol Chem 274(43):30858-63. 
Carter AB, Monick MM, Hunninghake GW (1999b). Both Erk and p38 Kinases Are 
Necessary for Cytokine Gene Transcription. Am. J. Respir. Cell Mo/. Biol. 20(4):751-
758. 
Cerami A, Beutler B (1988). The role of cachectin/TNF in endotoxic shock and cachexia. 
lmmunol Today 9(1):28-31. 
Chaudhary PM, Ferguson C, Nguyen V, Nguyen 0, Massa HF, Eby M, Jasmin A, Trask 
BJ, Hood L, Nelson PS (1998). Cloning and characterization of two Toll/Interleukin-I 
receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. 
Blood 91(11):4020-7. 
Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, Liu SC, Low PS, 
Rouleau GA, Mohandas N, Chasis JA, Conboy JG, Gascard P, Takakuwa Y, Huang SC, 
Benz EJ, Jr., Bretscher A, Fehon RG, Gusella JF, Ramesh V, Solomon F, Marchesi VT, 
112 
Tsukita S, Hoover KB, et al. (1998). The FERM domain: a unique module involved in 
the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci 23(8):281-2. 
Chuang TH, Ulevitch RJ (2000). Cloning and characterization of a sub-family of human 
toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 11(3):372-8. 
Cobb RR, Felts KA, Parry GC, Mackman N (1996). D609, a phosphatidylcholine-
specific phospholipase C inhibitor, blocks interleukin- I beta-induced vascular cell 
adhesion molecule 1 gene expression in human endothelial cells. Mo/ Pharmacol 
49( 6):998-1004. 
Cohen L, Haziot A, Shen DR, Lin XY, Sia C, Harper R, Silver J, Goyert SM (1995). 
CD14-independent responses to LPS require a serum factor that is absent from neonates. 
J lmmunol 155(11):5337-42. 
Cuzzola M, Mancuso G, Beninati C, Biondo C, Genovese F, Tomasello F, Flo TH, 
Espevik T, Teti G (2000). Beta 2 integrins are involved in cytokine responses to whole 
Gram-positive bacteria. J lmmunol 164(1 I):5871-6. 
da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ (2001). 
Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor 
complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 276(24):21129-35. 
Daun JM, Fenton MJ (2000). Interleukin-I/Toll receptor family members: receptor 
structure and signal transduction pathways. J Interferon Cytokine Res 20(10):843-55. 
Davis RJ (1999). Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 
64(1-12. 
113 
Defranco AL, Crowley MT, Finn A, Hambleton J, Weinstein SL (1998). The role of 
tyrosine kinases and map kinases in LPS-induced signaling. Prog Clin Biol Res 397(119-
36. 
Dennison DK, Van Dyke TE (1997). The acute inflammatory response and the role of 
phagocytic cells in periodontal health and disease. Periodontol 2000 14(54-78. 
DiDonato JA, Hayakawa M, RothwarfDM, Zandi E, Karin M (1997). A cytokine-
responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 
388(6642):548-54. 
Dinarello CA (2000). The role of the interleukin- I-receptor antagonist in blocking 
inflammation mediated by interleukin- I. N Engl J Med 343(10):732-4. 
Ding AH, Sanchez E, Srimal S, Nathan CF (1989). Macrophages rapidly internalize their 
tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem 
264(7):3924-9. 
Du X, Poltorak A, Wei Y, Beutler B (2000). Three novel mammalian toll-like receptors: 
gene structure, expression , and evolution. Eur Cytokine Netw 11(3):362-71. 
Dustin ML, Rothlein R, Bhan AK, Dinarello CA , Springer TA ( 1986). Induction by IL 1 
and interferon-gamma: tissue distribution, biochemistry, and function of a natural 
adherence molecule (ICAM-1). J lmmunol 137(1):245-54. 
Dziarski R (1991). Peptidoglycan and lipopolysaccharide bind to the same binding site on 
lymphocytes. J Biol Chem 266(8):4719-25. 
114 
Edwards SD, Keep NH (2001). The 2.7 A crystal structure of the activated FERM 
domain of moesin: an analysis of structural changes on activation. Biochemistry 
40(24):7061-8. 
El-Samalouti VT, Schletter J, Brade H, Brade L, Kusumoto S, Rietschel ET, Flad HD, 
Ulmer AJ (1997). Detection oflipopolysaccharide (LPS)-binding membrane proteins by 
immuno-coprecipitation with LPS and anti-LPS antibodies. Eur J Biochem 250(2):418-
24. 
Faure S, Salazar-Fontana LI, Semichon M, Tybulewicz VL, Bismuth G, Trautmann A, 
Germain RN, Delon J (2004). ERM proteins regulate cytoskeleton relaxation promoting 
T cell-APC conjugation. Nat Immunol 5(3):272-9. 
Ferrero E, Goyert SM (1988). Nucleotide sequence of the gene encoding the monocyte 
differentiation antigen, CD14. Nucleic Acids Res 16(9):4173. 
Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM (1993). 
Transgenic mice expressing human CD 14 are hypersensitive to lipopolysaccharide. Proc 
Natl Acad Sci US A 90(6):2380-4. 
Finnerty CM, Chambers D, Ingraffea J, Faber HR, Karplus PA, Bretscher A (2004). The 
EBP50-moesin interaction involves a binding site regulated by direct masking on the 
FERM domain. J Cell Sci 117(Pt 8):1547-52. 
Fischer C, Page S, Weber M, Eisele T, Neumeier D, Brand K (1999). Differential effects 
of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome 
activation and IkappaB proteolysis. J Biol Chem 274(35):24625-32. 
115 
Forman-Kay JD, Pawson T (1999). Diversity in protein recognition by PTB domains. 
Curr Opin Struct Biol 9(6):690-5. 
Franck Z, Gary R, Bretscher A (1993). Moesin, like ezrin, colocalizes with actin in the 
cortical cytoskeleton in cultured cells, but its expression is more variable. J Cell Sci 
105(Pt 1 ):219-31. 
Fujihara M, Muroi M, Muroi Y, Ito N, Suzuki T (1993). Mechanism of 
lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774). 
J Biol Chem 268(20): 14898-905. 
Fujihara M, Connolly N, Ito N, Suzuki T (1994). Properties of protein kinase C isoforms 
(beta II, epsilon, and zeta) in a macrophage cell line (J774) and their roles in LPS-
induced nitric oxide production. J Immunol 152(4):1898-906. 
Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H (2003). Molecular 
mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of 
the receptor complex. Pharmacol Ther 100(2): 171-94. 
Fukata Y, Kimura K, Oshiro N, Saya H, Matsuura Y, Kaibuchi K (1998). Association of 
the myosin-binding subunit of myosin phosphatase and moesin: dual regulation of 
moesin phosphorylation by Rho-associated kinase and myosin phosphatase. J Cell Biol 
141(2):409-18. 
Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP (1993a). Lipopolysaccharide-
binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl 
Acad Sci US A 90(21):9935-8. 
116 
Gallay P, Jongeneel CV, Barras C, Bumier M, Baumgartner JD, Glauser MP, Heumann 
D (1993b ). Short time exposure to lipopolysaccharide is sufficient to activate human 
monocytes. J Immuno/ 150(11):5086-93. 
Gauldie J, Richards C, Hamish D, Lansdorp P, Baumann H (1987). Interferon beta 2/B-
cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-
stimulating factor and regulates the major acute phase protein response in liver cells. 
Proc Natl Acad Sci US A 84(20):7251-5. 
Gautreau A, Louvard D, Arpin M (2002). ERM proteins and NF2 tumor suppressor: the 
Yin and Yang of cortical actin organization and cell growth signaling. Curr Opin Cell 
Biol 14(1 ): I 04-9. 
Gay NJ, Keith FJ (1991). Drosophila Toll and IL-I receptor. Nature 351(6325):355-6. 
Gegner JA, Ulevitch RJ, Tobias PS (1995). Lipopolysaccharide (LPS) signal transduction 
and clearance. Dual roles for LPS binding protein and membrane CD 14. J Biol Chem 
270(10):5320-5. 
Ghosh S, May MJ, Kopp EB (1998). NF-kappa Band Rel proteins: evolutionarily 
conserved mediators of immune responses. Annu Rev Immunol 16(225-60. 
Gifford GE, Flick DA (1988). Tumour necrosis factor. Microbial Sci 5(4):104-7. 
Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA (1993). Surface 
expression of human CD 14 in Chinese hamster ovary fibroblasts imparts macrophage-
like responsiveness to bacterial endotoxin. J Biol Chem 268(29):22055-9. 
117 
Gordon S, Peny VH , Rabinowitz S, Chung LP , Rosen H (1988). Plasma membrane 
receptors of the mononuclear phagocyte system. J Cell Sci Suppl 9( 1-26. 
Gordon S ( 1999). Macrophage-restricted molecules: role in differentiation and activation. 
lmmunol Lett 65(1-2):5-8. 
Guha M, Mackman N (2001 ). LPS induction of gene expression in human monocytes. 
Cell Signal 13(2):85-94. 
Guha M, O'Connell MA , Pawlinski R, Hollis A, McGovern P, Yan SF, Stem D, 
Mackman N (2001). Lipopolysaccharide activation of the MEK-ERK.1/2 pathway in 
human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression 
by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98(5):1429-39. 
Gupta S, Barrett T, Whitmarsh A, Cavanagh J, Sluss H, Derijard B , Davis R (1996). 
Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 
15(11 ):2760-2770. 
Hajishengallis G, Martin M, Schifferle RE, Genco RJ (2002). Counteracting interactions 
between lipopolysaccharide molecules with differential activation of toll-like receptors. 
Infect lmmun 70(12):6658-64. 
Hale KK, Trollinger D, Rihanek M, Manthey CL (1999). Differential Expression and 
Activation ofp38 Mitogen-Activated Protein Kinase {alpha}, {beta}, {gamma}, and 
{delta} in Inflammatory Cell Lineages. J lmmunol 162(7):4246-4252. 
Hambleton J, McMahon M, DeFranco AL (1995). Activation ofRaf-1 and mitogen-
activated protein kinase in murine macrophages partially mimics lipopolysaccharide-
induced signaling events. J Exp Med 182(1):147-54. 
118 
Hambleton J, Weinstein SL, Lem L, Defranco AL (1996). Activation of c-Jun N-
terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad 
Sci US A 93(7):2774-8. 
Han J, Lee JD, Bibbs L, Ulevitch RJ (1994a). A MAP kinase targeted by endotoxin and 
hyperosmolarity in mammalian cells. Science 265(5173):808-1 l. 
Han J, Mathison JC, Ulevitch RJ, Tobias PS (1994b). Lipopolysaccharide (LPS) binding 
protein, truncated at Ile-197 , binds LPS but does not transfer LPS to CD 14. J Biol Chem 
269(11):8172-5. 
Hawiger J, Veach RA, Liu XY, Timmons S, Ballard DW (1999). IkappaB kinase 
complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic 
cells. Blood 94(5): 1711-6. 
Hawiger J (2001 ). Innate immunity and inflammation: a transcriptional paradigm. 
Immunol Res 23(2-3):99-109. 
Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM (1988). The monocyte 
differentiation antigen, CD 14, is anchored to the cell membrane by a phosphatidylinositol 
linkage. J Immunol 141(2):547-52. 
Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL, Goyert SM 
(1996). Resistance to endotoxin shock and reduced dissemination of gram- negative 
bacteria in CD 14-deficient mice. Immunity 4( 4 ):407-14. 
Helander TS, Carpen 0, Turunen 0, Kovanen PE, Vaheri A, Timonen T (1996). ICAM-2 
redistributed by ezrin as a target for killer cells. Nature 382(6588):265-8. 
119 
Hellman J, Loiselle PM, Tehan MM, Allaire JE, Boyle LA, Kumick JT, Andrews DM, 
Sik Kim K, Warren HS (2000). Outer membrane protein A, peptidoglycan-associated 
lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum. 
Infect Immun 68(5):2566-72. 
Henricson BE, Carboni JM, Burkhardt AL, Vogel SN (1995). LPS and Taxol activate 
Lyn kinase autophosphorylation in Lps(n), but not in Lpsd), macrophages. Mo! Med 
1(4):428-35. 
Henry MD, Gonzalez Agosti C, Solomon F (1995). Molecular dissection of radixin: 
distinct and interdependent functions of the amino- and carboxy-terminal domains. J Cell 
Biol 129(4):1007-22. 
Herrera-Velit P, Knutson KL, Reiner NE (1997). Phosphatidylinositol 3-kinase-
dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated 
human monocytes. J Biol Chem 272(26):16445-52. 
Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S 
(1996). Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane 
association: possible involvement of phosphatidylinositol turnover and Rho-dependent 
signaling pathway. J Cell Biol 135(1):37-51. 
Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ (2000). Cutting Edge: Repurification 
ofLipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like 
Receptor 2. J Immunol 165(2):618-622. 
120 
Hoebe K, Du X, Goode J, Mann N, Beutler B (2003). Lps2: a new locus required for 
responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic 
screening. J Endotoxin Res 9(4):250-5. 
Hoshino K, Takeuchi 0 , Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S 
(1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to 
lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162(7):3749-
52. 
Imler JL, Hoffmann JA (2000). Signaling mechanisms in the antimicrobial host defense 
of Drosophila. Curr Opin Microbiol 3(1 ): 16-22. 
Ingalls RR, Golenbock DT (1995). CD1 lc/CD18, a transmembrane signaling receptor for 
lipopolysaccharide. J Exp Med 181(4):1473-9. 
Ingalls RR, Arnaout MA, Golenbock DT (1997). Outside-in signaling by 
lipopolysaccharide through a tailless integrin. J Immunol l 59(1 ):433-8. 
Ingalls RR, Monks BG, Savedra R, Jr., Christ WJ, Delude RL, Medvedev AE, Espevik T, 
Golenbock DT (1998). CD1 l/CD18 and CD14 share a common lipid A signaling 
pathway. J Immuno/ 161(10):5413-20. 
Iontcheva I, Amar S, Zawawi KH, Kantarci A, Van Dyke TE (2004). Role for moesin in 
lipopolysaccharide-stimulated signal transduction. Infect Immun 72(4):2312-20 . 
Ip YT , Davis RJ (1998). Signal transduction by the c-Jun N-terminal kinase (JNK)--from 
inflammation to development. Curr Opin Cell Biol 10(2):205-19. 
121 
Irie T, Muta T, Takeshige K (2000). TAKI mediates an activation signal from toll-like 
receptor(s) to nuclear factor-kappaB in lipopolysaccharide-stimulated macrophages. 
FEBS Lett 467(2-3): 160-4. 
Israel A (2000). The IKK complex: an integrator of all signals that activate NF-kappaB? 
Trends Cell Biol 10(4):129-33. 
lvetic A, Deka J, Ridley A, Ager A (2002). The cytoplasmic tail ofL-selectin interacts 
with members of the Ezrin-Radixin-Moesin (ERM) family of proteins: cell activation-
dependent binding ofMoesin but not Ezrin. J Biol Chem 277(3):2321-9. 
Ivetic A, Florey 0, Deka J, Haskard DO, Ager A, Ridley AJ (2004). Mutagenesis of the 
Ezrin-Radixin-Moesin (ERM) binding domain of L-selectin tail affects shedding, 
microvillar positioning and leukocyte tethering. J Biol Chem. 
Ivetic A, Ridley AJ (2004). Ezrin/radixin/moesin proteins and Rho GTPase signalling in 
leucocytes. Immunology 112(2):165-76. 
Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Furll 
B, Freudenberg M, Schmitz G, Stelter F, Schutt C ( 1997). Lipopolysaccharide-binding 
protein is required to combat a murine gram- negative bacterial infection. Nature 
389(6652):742-5. 
Jakway JP, DeFranco AL ( 1986). Pertussis toxin inhibition of B cell and macrophage 
responses to bacterial lipopolysaccharide. Science 234(4777):743-6. 
Janknecht R, Hunter T (1997). Activation of the Sap-la Transcription Factor by the c-Jun 
N-terminal Kinase (JNK) Mitogen-activated Protein Kinase. J. Biol. Chem. 272(7):4219-
4224. 
122 
Jefferies CA, O'Neill LA (2000). Rael regulates interleukin I-induced nuclear factor 
kappaB activation in an inhibitory protein kappaBalpha-independent manner by 
enhancing the ability of the p65 subunit to transactivate gene expression. J Biol Chem 
275(5):3114-20. 
Jiang Q, Akashi S, Miyake K, Petty HR (2000). Lipopolysaccharide induces physical 
proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of 
NF-kappa B. J Immunol 165(7):3541-4. 
Joshi VD, Kalvakolanu DV, Cross AS (2003). Simultaneous activation of apoptosis and 
inflammation in pathogenesis of septic shock: a hypothesis. FEES Lett 555(2): 180-4. 
Kamovsky ML ( 1981). Metchnikoff in Messina: a century of studies on phagocytosis. N 
Engl J Med 304(19): 1178-80. 
Kawasaki K, Nogawa H, Nishijima M (2003). Identification of mouse MD-2 residues 
important for forming the cell surface TLR4-MD-2 complex recognized by anti-TLR4-
MD-2 antibodies, and for conferring LPS and taxol responsiveness on mouse TLR4 by 
alanine-scanning mutagenesis. J Immunol l 70(1):413-20. 
Kay J, Calabrese L (2004). The role of interleukin-I in the pathogenesis of rheumatoid 
arthritis. Rheumatology (Oxford) 43(Suppl_3):1112-1119. 
Keresztes M, Lajtos Z, Fischer J, Dux L (1998). Moesin becomes linked to the plasma 
membrane in attached neutrophil granulocytes. Biochem Biophys Res Commun 
252(3 ):723- 7. 
123 
Kiger N, Khalil A, Mathe G (1980). Tumor-necrotizing serum production by 
administration of BCG + Pseudomonas: its application in treatment of fibrosarcoma in 
mice. Recent Results Cancer Res 75(220-5. 
Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P (1989). The inducing role of 
tumor necrosis factor in the development of bactericidal granulomas during BCG 
infection. Cell 56(5):731-40. 
Kirkland TN, Virca GD, Kuus-Reichel T, Multer FK, Kim SY, Ulevitch RJ, Tobias PS 
(1990). Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by 
photoaffinity cross-linking. J Biol Chem 265(16):9520-5. 
Kirschning CJ, Wesche H, Merrill Ayres T, Rothe M (1998). Human toll-like receptor 2 
confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188(11):2091-7. 
Koeffler HP, Golde DW (1980). Human myeloid leukemia cell lines: a review. Blood 
56(3):344-50. 
Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita S (1997). ERM 
( ezrin/radixin/moesin)-based molecular mechanism of microvillar breakdown at an early 
stage of apoptosis. J Cell Biol 139(3):749-58. 
Kopp E, Medzhitov R, Carothers J, Xiao C, Douglas I, Janeway CA, Ghosh S (1999). 
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-I signal transduction 
pathway. Genes Dev 13(16):2059-71. 
Kotani S, Takada H, Tsujimoto M, Ogawa T, Takahashi I, Ikeda T, Otsuka K, Shimauchi 
H, Kasai N, Mashimo J, et al. ( 1985). Synthetic lipid A with endotoxic and related 
124 
biological activities comparable to those of a natural lipid A from an Escherichia coli re-
mutant Infect lmmun 49( 1):225-37. 
Kragelund BB, Andersen KV, Madsen JC, Knudsen J, Poulsen FM (1993). Three-
dimensional structure of the complex between acyl-coenzyme A binding protein and 
palmitoyl-coenzyme A. J Mol Biol 230(4):1260-77. 
Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227(259):680-5. 
Lamping N, Hoess A, Yu B, Park TC, Kirschning CJ, Pfeil D, Reuter D, Wright SD, 
Herrmann F, Schumann RR ( 1996). Effects of site-directed mutagenesis of basic residues 
(Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and 
transfer ofLPS and subsequent immune cell activation. J lmmunol 157(10):4648-56. 
Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR 
(1998). LPS-binding protein protects mice from septic shock caused by LPS or gram-
negative bacteria. J Clin Invest 101 ( 10):2065-71. 
Landmann R, Ludwig C, Obrist R, Obrecht JP ( 1991 ). Effect of cytokines and 
lipopolysaccharide on CD 14 antigen expression in human monocytes and macrophages. J 
Cell Biochem 47(4):317-29. 
Lankes W, Griesmacher A, Grunwald J, Schwartz-Albiez R, Keller R (1988). A heparin-
binding protein involved in inhibition of smooth-muscle cell proliferation. Biochem J 
251(3):831-42. 
Lankes WT, Furthmayr H (1991). Moesin: a member of the protein 4.1-talin-ezrin family 
of proteins. Proc Natl Acad Sci US A 88(19):8297-301. 
125 
Lankes WT, Schwartz-Albiez R, Furthmayr H (1993). Cloning and sequencing of porcine 
moesin and radixin cDNA and identification of highly conserved domains. Biochim 
Biophys Acta 1216(3):479-82. 
Lee FS, Hagler J, Chen ZJ, Maniatis T (1997). Activation of the IkappaB alpha kinase 
complex by MEKK.1, a kinase of the JNKpathway. Cell 88(2):213-22. 
Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ (1992). Transfection of CD14 into 
70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide 
(LPS) and LPS binding protein. J Exp Med 175(6):1697-705. 
Lei MG, Morrison DC (1988). Specific endotoxic lipopolysaccharide-binding proteins on 
murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and 
splenocyte subpopulations. J Immunol l4l(3):996-l005. 
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996). The dorsoventral 
regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in 
Drosophila adults. Cell 86(6):973-83. 
Ley K (1996). Molecular mechanisms ofleukocyte recruitment in the inflammatory 
process. Cardiovasc Res 32(4):733-42. 
Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa 
M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT (2000). Toll-like 
receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin 
Invest l 05( 4 ):497-504. 
Lien E, Ingalls RR (2002). Toll-like receptors. Crit Care Med 30(1 Suppl):S1-11. 
126 
Lindemann RA, Economou JS ( 1988). Actinobacillus actinomycetemcomitans and 
Bacteroides gingivalis activate human peripheral monocytes to produce interleukin- I and 
tumor necrosis factor. J Periodontal 59(11 ):728-30. 
Listgarten MA (1987). Nature of periodontal diseases: pathogenic mechanisms. J 
Periodontal Res 22(3): 172-8. 
Lo YJ, Liu CM, Wong MY, Hou LT, Chang WK (1999). Interleukin I beta-secreting cells 
in inflamed gingival tissue of adult periodontitis patients. Cytoldne 11(8):626-33. 
Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli 
C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, 
Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW 
(1999). TRAF6 deficiency results in osteopetrosis and defective interleukin-I, CD40, and 
LPS signaling. Genes Dev 13(8):1015-24. 
Loppnow H, Brade H, Durrbaum I, Dinarello CA, Kusumoto S, Rietschel ET, Flad HD 
( 1989). IL- I induction-capacity of defined lipopolysaccharide partial structures. J 
Immunol l42(9):3229-38. 
Louvet-Vallee S (2000). ERM proteins: from cellular architecture to cell signaling. Biol 
Cell 92( 5):305-16. 
Lugtenberg B, Van Alphen L (1983). Molecular architecture and functioning of the outer 
membrane of Escherichia coli and other gram-negative bacteria. Biochim Biophys Acta 
737(1):51-115. 
127 
Lynn WA, Liu Y, Golenbock DT (1993). Neither CD14 nor serum is absolutely 
necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. 
Infect Immun 61(10):4452-61. 
Mackay DJ, Esch F, Furthmayr H, Hall A (1997). Rho- and rac-dependent assembly of 
focal adhesion complexes and actin filaments in permeabilized fibroblasts: an essential 
role for ezrin/radixin/moesin proteins. J Cell Biol 138(4):927-38. 
Mackman N, Brand K, Edgington TS ( 1991 ). Lipopolysaccharide-mediated 
transcriptional activation of the human tissue factor gene in THP-1 monocytic cells 
requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 
174(6):1517-26. 
Mancuso G, Midiri A, Beninati C, Piraino G, Valenti A, Nicocia G, Teti D, Cook J, Teti 
G (2002). Mitogen-activated protein kinases and NF-kappa Bare involved in TNF-alpha 
responses to group B streptococci. J Immunol 169(3 ): 1401-9. 
Manthey CL, Wang SW, Kinney SD, Yao Z (1998). SB202190, a selective inhibitor of 
p38 mitogen-activated protein kinase, is a powerful regulator ofLPS-induced mRNAs in 
monocytes. J Leukoc Biol 64(3 ):409-1 7. 
Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada 
H, Moore M, Williamson B, Basu S, Old LJ (1997). Characterization of tumor necrosis 
factor-deficient mice. Proc Natl Acad Sci US A 94(15):8093-8. 
Martin AG, Fresno M (2000). Tumor necrosis factor-alpha activation of NF-kappa B 
requires the phosphorylation of Ser-4 71 in the transactivation domain of c-Rel. J Biol 
Chem 275(32):24383-91. 
128 
Masumoto J, Sagara J, Hayama M, Hidaka E, Katsuyama T, Taniguchi S (1998). 
Differential expression of moesin in cells of hematopoietic lineage and lymphatic 
systems. Histochem Cell Biol 110(1):33-41. 
Mathison JC, Wolfson E, Ulevitch RJ (1988) . Participation of tumor necrosis factor in the 
mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin 
Invest 81(6):1925-37. 
Matsui T, Maeda M, Doi Y, Yonemura S, Amano M , Kaibuchi K, Tsukita S (1998). Rho-
kinase phosphorylates COOR-terminal threonines of ezrin/radixin/moesin (ERM) 
proteins and regulates their head-to-tail association. J Cell Biol 140(3):647-57. 
May MJ , Ghosh S (1998). Signal transduction through NF-kappa B. Immunol Today 
19(2):80-8. 
Means TK, Golenbock DT, Fenton MJ (2000). The biology of Toll-like receptors. 
Cy tokine Growth Factor Rev 11(3):219-32. 
Medvedev AE , Flo T, Ingalls RR, Golenbock DT , Teti G, Vogel SN, Espevik T (1998). 
Involvement of CD 14 and complement receptors CR3 and CR4 in nuclear factor-kappaB 
activation and TNF production induced by lipopolysaccharide and group B streptococcal 
cell walls. J Immunol 160(9):4535-42. 
Medvedev AE , Kopydlowski KM , Vogel SN (2000). Inhibition of lipopolysaccharide-
induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of 
cytokine , chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 
164(11):5564-74 . 
129 
Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. (1997). A human homologue of the 
Drosophila Toll protein signals activation of adaptive immunity. Nature 388(6640):394-
7. 
Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway CA, Jr. 
(1998). MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling 
pathways. Mo/ Cell 2(2):253-8. 
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa 
M, Mann M, Manning A, Rao A (1997). IKK-1 and IKK-2: cytokine-activated IkappaB 
kinases essential for NF-kappaB activation. Science 278(5339):860-6. 
MetcalfD (1971). Transformation of granulocytes to macrophages in bone marrow 
colonies in vitro. J Cell Physiol 77(2):277-80. 
Meuret G, Hoffmann G (1973). Monocyte kinetic studies in normal and disease states. Br 
J Haematol 24(3):275-85. 
Minden A, Karin M (1997). Regulation and function of the JNK subgroup of MAP 
kinases. Biochim Biophys Acta 1333(2):F85-104. 
Miyake K, Yamashita Y, Ogata M, Sudo T, Kimoto M (1995). RP105, a novel B cell 
surface molecule implicated in B cell activation, is a member of the leucine-rich repeat 
protein family. J Jmmunol 154(7):3333-40. 
Miyake K, Shimazu R, Kondo J, Niki T, Akashi S, Ogata H, Yamashita Y, Miura Y, 
Kimoto M (1998). Mouse MD-1, a molecule that is physically associated with RP105 and 
positively regulates its expression. J lmmunol 161(3):1348-53. 
130 
Miyake K (2004 ). Endotoxin recognition molecules , Toll-like receptor 4-MD-2 . Semin 
lmmunol 16(1):11-6. 
Miyauchi M, Sato S, Kitagawa S, Hiraoka M, Kudo Y, Ogawa I, Zhao M, Takata T 
(2001 ). Cytokine expression in rat molar gingival periodontal tissues after topical 
application of lipopolysaccharide. His toe hem Cell Biol 116( 1):57-62. 
Monick MM , Powers L, Butler N, Yarovinsky T, Hunninghake GW (2002). Interaction 
of matrix with integrin receptors is required for optimal LPS-induced MAP kinase 
activation. Am J Phy siol Lung Cell Mo/ Physiol 283(2):L390-402 . 
Moore MA, MetcalfD (1970). Ontogeny of the haemopoietic system: yolk sac origin of 
in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 
18(3 ): 279-96. 
Morrison DC, Ryan JL (1987). Endotoxins and disease mechanisms. Annu Rev Med 
38(417-32 . 
Muller JM, Ziegler-Heitbrock HW, Baeuerle PA (1993). Nuclear factor kappa B, a 
mediator of lipopolysaccharide effects. lmmunobiology 187(3-5):233-56. 
Muller-Loennies S, Zahringer U, Seydel U, Kusumoto S, Ulmer AJ, Rietschel ET (1998). 
What we know and don't know about the chemical and physical structure of 
lipopolysaccharide in relation to biological activity. Prog Clin Biol Res 3 97 ( 51-72. 
Muroi M, Muroi Y, Yamamoto K, Suzuki T ( 1993 ). Influence of 3' half-site sequence of 
NF-kappa B motifs on the binding of lipopolysaccharide-activatable macrophage NF-
kappa B proteins. J Biol Chem 268(26): 19534-9. 
131 
Muroi M, Suzuki T (1993). Role of protein kinase A in LPS-induced activation ofNF-
kappa B proteins of a mouse macrophage-like cell line, 1774. Cell Signal 5(3):289-98. 
Muta T, Takeshige K (2001). Essential roles of CD14 and lipopolysaccharide-binding 
protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of 
TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur J 
Biochem 268(16):4580-9. 
Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A (1998). The human toll 
signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation 
upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 
187(12):2097-101. 
Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, 
Kimoto M, Miyake K (2002). Essential role ofMD-2 in LPS responsiveness and TLR4 
distribution. Nat Jmmunol 3(7):667-72. 
Nakamura F, Amieva MR, Furthmayr H (1995). Phosphorylation of threonine 558 in the 
carboxyl-terminal actin-binding domain of moesin by thrombin activation of human 
platelets. J Biol Chem 270(52):31377-85. 
Nakamura F, Amieva MR, Hirota C, Mizuno Y, Furthmayr H (1996). Phosphorylation of 
558T of moesin detected by site-specific antibodies in RA W264. 7 macrophages. Biochem 
Biophys Res Commun 226(3):650-6. 
Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K (1998). 
Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-
kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase- I. Proc 
Natl Acad Sci US A 95(7):3537-42. 
132 
Nathan CF (1987). Secretory products of macrophages. J Clin Invest 79(2):319-26. 
Naumann M, Scheidereit C (1994). Activation of NF-kappa Bin vivo is regulated by 
multiple phosphorylations. Embo J 13(19):4597-607. 
Niggli V (2001 ). Structural properties of lipid-binding sites in cytoskeletal proteins. 
Trends Biochem Sci 26( 10):604-11. 
Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, 
Miyake K, Takeda K, Akira S (2000). Cutting edge: endotoxin tolerance in mouse 
peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 
expression. J Immunol 164(7):3476-9. 
Norris JL, Baldwin AS, Jr. (1999). Oncogenic Ras enhances NF-kappaB transcriptional 
activity through Raf-dependent and Raf-independent mitogen-activated protein kinase 
signaling pathways. J Biol Chem 274(20):13841-6. 
O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N ( 1998). Role of 
IKKl and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 
273( 46):30410-4. 
Ohnishi T, Muroi M, Tanamoto K (2003). MD-2 is necessary for the toll-like receptor 4 
protein to undergo glycosylation essential for its translocation to the cell surface. Clin 
Diagn Lab Immunol 10(3):405-10. 
O'Neill LA, Greene C (1998). Signal transduction pathways activated by the IL-1 
receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc 
Biol 63(6):650-7. 
133 
Page RC, Kornman KS (1997). The pathogenesis of human periodontitis: an introduction. 
Periodontal 2000 14(9-11. 
Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997). Advances in 
the pathogenesis of periodontitis: summary of developments , clinical implications and 
future directions. Periodontal 2000 14(216-48. 
Paglini G, Kunda P, Quiroga S, Kosik K, Caceres A (1998). Suppression ofradixin and 
moesin alters growth cone morphology, motility, and process formation in primary 
cultured neurons. J Cell Biol 143(2):443-55. 
Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M, Schaer GL, 
Palmeri ST, Cannon RO, 3rd, Alling D, et al. (1989). A prospective, randomized, 
controlled trial ofprednisone for dilated cardiomyopathy. N Engl J Med 321(16):1061-8. 
Parrillo JE (1993). Pathogenetic mechanisms of septic shock. N Engl J Med 
328(20):1471-7. 
Pearson MA, Reczek D, Bretscher A, Karplus PA (2000). Structure of the ERM protein 
moesin reveals the FERM domain fold masked by an extended actin binding tail domain. 
Cell 101(3):259-70. 
Perera PY, Mayadas TN, Takeuchi 0, Akira S, Zaks-Zilberman M, Goyert SM, Vogel 
SN (2001). CD1 lb/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to 
elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166( 1 ): 57 4-
81. 
134 
Pietromonaco SF, Simons PC, Altman A, Elias L ( 1998). Protein kinase C-theta 
phosphorylation ofmoesin in the actin-binding sequence. J Biol Chem 273(13):7594-603. 
Poltorak A, He X, Smimova I, Liu MY, Ruffel CV, Du X, Birdwell D, Alejos E, Silva 
M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B (1998a). 
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. 
Science 282(5396):2085-8. 
Poltorak A, Smimova I, He X, Liu MY, Van Ruffel C, McNally 0, Birdwell D, Alejos E, 
Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler 
B (1998b). Genetic and physical mapping of the Lps locus: identification of the toll-4 
receptor as a candidate gene in the critical region. Blood Cells Mo/ Dis 24(3):340-55. 
Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B (2000). Physical contact 
between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. 
Proc Natl Acad Sci US A 97(5):2163-7. 
Pugin J, Schurer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS (1993). 
Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by 
lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci US A 
90(7):2744-8. 
Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser 
MP, Tobias PS, Ulevitch RJ (1994). CD14 is a pattern recognition receptor. Immunity 
1(6):509-16. 
Quentmeier H, Duschl A, Hu ZB, Schnarr B, Zaborski M, Drexler HG (1996). MUTZ-3, 
a monocytic model cell line for interleukin-4 and lipopolysaccharide studies. Immunology 
89(4):606-12. 
135 
Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, Malo D (1999). 
Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 
189(4):615-25. 
Raetz CR (1990). Biochemistry of endotoxins. Annu Rev Biochem 59(129-70. 
Raetz CR, Whitfield C (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 
71(635-700. 
Rahmsdorf HJ (1996). Jun: transcription factor and oncoprotein. J Mo/ Med 74(12):725-
47. 
Ramadori G, Meyer zum Buschenfelde KH, Tobias PS, Mathison JC, Ulevitch RJ (1990). 
Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 
58(2):89-94. 
Raschi E, Testoni C, Bosisio D, Borghi MO, Koike T, Mantovani A, Meroni PL (2003). 
Role of the MyD88 transduction signaling pathway in endothelial activation by 
antiphospholipid antibodies. Blood 101(9):3495-500. 
Re F, Strominger JL (2002). Monomeric recombinant MD-2 binds toll-like receptor 4 
tightly and confers lipopolysaccharide responsiveness. J Biol Chem 277(26):23427-32. 
Reynolds JJ, Meikle MC (1997). Mechanisms of connective tissue matrix destruction in 
periodontitis. Periodontol 2000 14( 144-57. 
Riedemann NC, Guo RF, Ward PA (2003). The enigma of sepsis. J Clin Invest 
112(4):460-7. 
136 
Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, 
Zahringer U, Seydel U, Di Padova F, et al. (1994). Bacterial endotoxin: molecular 
relationships of structure to activity and function. Faseb J8(2):2l 7-25. 
Roberts IS ( 1996). The biochemistcy and genetics of capsular polysaccharide production 
in bacteria. Annu Rev Microbiol 50(285-315. 
Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF (1998). A family of human 
receptors structurally related to Drosophila Toll. Proc Natl Acad Sci US A 95(2):588-93. 
Rodeberg DA, Morris RE, Babcock GF (1997). Azurophilic granules of human 
neutrophils contain CDl4. Infect Jmmun 65(11):4747-53. 
Rothlein R, Dustin ML , Marlin SD, Springer TA (1986). A human intercellular adhesion 
molecule (ICAM-1) distinct from LFA-1. J lmmunol 137(4):1270-4. 
Rutault K, Hazzalin CA, Mahadevan LC (2001). Combinations of ERK and p38 MAPK 
inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence 
for selective destabilization of TNF-alpha transcripts. J Biol Chem 27 6(9):6666-74. 
Sagara J, Tsukita S, Yonemura S, Kawai A (1995). Cellular actin-binding ezrin-radixin-
moesin (ERM) family proteins are incorporated into the rabies virion and closely 
associated with viral envelope proteins in the cell. Virology 206(1 ):485-94. 
Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W (1999). IkappaB kinases 
phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol 
Chem 274(43):30353-6. 
137 
Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S (1992). A gene family 
consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma 
membrane association sites. J Cell Sci 103(Pt 1):131-43. 
Sato S, Takeuchi 0, Fujita T, Tomizawa H, Takeda K, Akira S (2002). A variety of 
microbial components induce tolerance to lipopolysaccharide by differentially affecting 
MyD88-dependent and -independent pathways. Int Immunol 14(7):783-91. 
Schmitz ML, dos Santos Silva MA, Baeuerle PA (1995). Transactivation domain 2 (T A2) 
ofp65 NF-kappa B. Similarity to TAI and phorbol ester-stimulated activity and 
phosphorylation in intact cells. J Biol Chem 270(26): 15576-84. 
Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, Latz E, Monks BG, 
Schwartz DA, Miyake K, Golenbock DT (2001). Molecular genetic analysis of an 
endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 
abolishes endotoxin-induced signaling. J Exp Med 194(1):79-88. 
Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, 
Ulevitch RJ (1990). Structure and function of lipopolysaccharide binding protein. Science 
249( 4975): 1429-31. 
Schumann RR, Lamping N, Kirschning C, Knopf HP, Hoess A, Herrmann F (1994). 
Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation 
and sepsis. Biochem Soc Trans 22(1):80-2. 
Schumann RR, Zweigner J (1999). A novel acute-phase marker: lipopolysaccharide 
binding protein (LBP). Clin Chem Lab Med 37(3):271-4. 
Schutt C (1999). Cdl4. Int J Biochem Cell Biol 31(5):545-9. 
138 
Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999). Peptidoglycan-
and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol 
Chem 274(25):17406-9. 
Schwartz DA (2001). The role ofTLR4 in endotoxin responsiveness in humans. J 
Endotoxin Res 7(5):389-93. 
Sechi AS, W ehland J (2000). The actin cytoskeleton and plasma membrane connection: 
Ptdlns( 4,5)P(2) influences cytoskeletal protein activity at the plasma membrane. J Cell 
Sci 113 Pt 21(3685-95. 
Shapira L, Takashiba S, Amar S, Van Dyke TE (1994a). Porphyromonas gingivalis 
lipopolysaccharide stimulation of human monocytes: dependence on serum and CD 14 
receptor. Oral Microbiol Immunol 9(2):l 12-7. 
Shapira L, Takashiba S, Champagne C, Amar S, Van Dyke TE (1994b). Involvement of 
protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha 
and IL-1 beta production by human monocytes. J Immunol l53(4):l8l8-24. 
Sherry B, Cerami A ( 1988). Cachectin/tumor necrosis factor exerts endocrine , paracrine , 
and autocrine control of inflammatory responses. J Cell Biol 107(4):1269-77. 
Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira 
S (1999). IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB 
kinases. Int Immunol l l(S):1357-62. 
139 
Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M (1999). 
MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll- like receptor 
4. J Exp Med 189(11):1777-82. 
Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, Suzuki M, Kogishi K, Serikawa T, 
Honjo T ( 1999). Alymphoplasia is caused by a point mutation in the mouse gene 
encoding Nf-kappa b-inducing kinase. Nat Genet 22(1 ):74-7. 
Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB (1985). Cloning and expression in 
Escherichia coli of the gene for human tumour necrosis factor. Nature 313(6005):803-6. 
Shum DT, Galsworthy SB (1982). Stimulation ofmonocyte production by an endogenous 
mediator induced by a component from Listeria monocytogenes. Immunology 46(2):343-
51. 
Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B (1989). Monocyte antigen 
CD14 is a phospholipid anchored membrane protein. Blood 73(1):284-9. 
Simons PC, Pietromonaco SF, Reczek D, Bretscher A, Elias L (1998). C-terminal 
threonine phosphorylation activates ERM proteins to link the cell's cortical lipid bilayer 
to the cytoskeleton. Biochem Biophys Res Commun 253(3):561-5. 
Smedsrod B, De Bleser PJ, Braet F, Lovisetti P, Vanderkerken K, Wisse E, Geerts A 
(1994). Cell biology ofliver endothelial and Kupffer cells. Gut 35(11):1509-16. 
Stashenko P, Jandinski JJ, Fujiyoshi P, Rynar J, Socransky SS (1991). Tissue levels of 
bone resorptive cytokines in periodontal disease. J Periodontol 62(8):504-9. 
140 
Stefanova I, Corcoran ML, Horak EM, Wahl LM, Bolen JB, Horak ID ( 1993 ). 
Lipopolysaccharide induces activation of CD 14-associated protein tyrosine kinase 
p53/56lyn. J Biol Chem 268(28):20725-8. 
Strand V, Kavanaugh AF (2004). The role of interleukin-I in bone resorption in 
rheumatoid arthritis. Rheumatology (Oxford) 43(Suppl_3):11110-III16. 
Su B, Karin M ( 1996). Mitogen-activated protein kinase cascades and regulation of gene 
expression. Curr Opin Immunol 8(3):402-l l. 
Swantek JL, Christerson L, Cobb MH ( 1999). Lipopolysaccharide-induced tumor 
necrosis factor-alpha promoter activity is inhibitor of nuclear factor-kappaB kinase-
dependent. J Biol Chem 274(17):11667-71. 
Swantek JL, Tsen MF, Cobb MH, Thomas JA (2000). IL-I receptor-associated kinase 
modulates host responsiveness to endotoxin. J Immunol 164(8):4301-6. 
Sweet MJ, Hume DA (1996). Endotoxin signal transduction in macrophages. J Leukoc 
Biol 60(1):8-26. 
Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, Irie K, Ninomiya-Tsuji J, 
Matsumoto K (2000). T AB2, a novel adaptor protein, mediates activation of TAKI 
MAPKKK by linking TAKI to TRAF6 in the IL-I signal transduction pathway. Mo/ Cell 
5(4):649-58. 
Takahashi K, Sasaki T, Mammoto A, Hotta I, Takaishi K, Imamura H, Nakano K, 
Kodama A, Takai Y (1998). Interaction of radixin with Rho small G protein GDP/GTP 
exchange protein Dbl. Oncogene 16(25):3279-84. 
141 
Takashiba S, Takigawa M, Takahashi K, Myokai F, Nishimura F, Chihara T, Kurihara H, 
Nomura Y, Murayama Y (1992). Interleukin-8 is a major neutrophil chemotactic factor 
derived from cultured human gingival fibroblasts stimulated with interleukin- I beta or 
tumor necrosis factor alpha. Infect Immun 60(12):5253-8. 
Takashiba S, Van Dyke TE, Shapira L, Amar S (1995). Lipopolysaccharide-inducible 
and salicylate-sensitive nuclear factor( s) on human tumor necrosis factor alpha promoter. 
Infect Immun 63(4):1529-34. 
Takashiba S, Van Dyke TE, Amar S, Murayama Y, Soskolne AW, Shapira L (1999). 
Differentiation of monocytes to macrophages primes cells for lipopolysaccharide 
stimulation via accumulation of cytoplasmic nuclear factor kappaB. Infect Immun 
67(11):5573-8. 
Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S 
(1994). Perturbation of cell adhesion and microvilli formation by antisense 
oligonucleotides to ERM family members. J Cell Bio/ 125(6):1371-84. 
Takeuchi 0, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S 
(1999). Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-
positive bacterial cell wall components. Immunity 11 ( 4 ):443-51. 
Talamas-Rohana P, Wright SD, Lennartz MR, Russell DG (1990). Lipophosphoglycan 
from Leishmania mexicana promastigotes binds to members of the CR3, p150,95 and 
LFA-1 family ofleukocyte integrins. J Immunol 144(12):4817-24. 
Taylor AH, Heavner G, Nedelman M, Sherris D, Brunt E, Knight D, Ghrayeb J (1995). 
Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS 
binding protein. J Biol Chem 270(30): 17934-8. 
142 
Theofan G, Hoiwitz AH, Williams RE , Liu PS, Chan I, Birr C, Carroll SF, Meszaros K, 
Parent JB, Kasler H, et al. (1994). An amino-terminal fragment of human 
lipopolysaccharide-binding protein retains lipid A binding but not CD 14-stimulatory 
activity. J lmmunol 152(7):3623-9. 
Thijs LG , de Boer JP, de Groot MC , Hack CE (1993). Coagulation disorders in septic 
shock. Intensive Care Med 19(Suppl 1):S8-15. 
Thompson PA , Tobias PS, Viriyakosol S, Kirkland TN , Kitchens RL (2003). 
Lipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPS. J Biol 
Chem 278(31):28367-71. 
Tobias PS, Soldau K, Ulevitch RJ (1986). Isolation of a lipopolysaccharide-binding acute 
phase reactant from rabbit serum. J Exp Med 164(3):777-93. 
Tobias PS, Soldau K, Ulevitch RJ (1989). Identification of a lipid A binding site in the 
acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264(18): 10867-71. 
Tobias PS, Ulevitch RJ (1993). Lipopolysaccharide binding protein and CD14 in LPS 
dependent macrophage activation. lmmunobiology 187(3-5):227-32. 
Tobias PS, Soldau K, Gegner JA, Mintz D, Ulevitch RJ (1995). Lipopolysaccharide 
binding protein-mediated complexation oflipopolysaccharide with soluble CD14. J Biol 
Chem 270(18):10482-8. 
Tohme ZN, Amar S, Van Dyke TE (1999). Moesin functions as a lipopolysaccharide 
receptor on human monocytes . Infect lmmun 67(7):3215-20. 
143 
Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, 
Fahey TJ , 3rd , Zentella A, Albert JD, et al. (1986). Shock and tissue injury induced by 
recombinant human cachectin. Science 234(4775):470-4. 
Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A 
(1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal 
bacteraemia. Nature 330(6149):662-4. 
Triantafilou K, Triantafilou M, Dedrick RL (2001). Interactions of bacterial 
lipopolysaccharide and peptidoglycan with a 70 kDa and an 80 kDa protein on the cell 
surface of CD 14+ and CD 14- cells. Hum lmmunol 62( 1 ): 50-63. 
Triantafilou M, Triantafilou K, Fernandez N (2000). Rough and smooth forms of 
fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent 
binding that is influencedby endotoxin concentration. Eur J Biochem 267(8):2218-26. 
Troelstra A, Antal-Szalmas P, de Graaf-Miltenburg LA, Weersink AJ, Verhoef J, Van 
Kessel KP, Van Strijp JA (1997). Saturable CD14-dependent binding of fluorescein-
labeled lipopolysaccharide to human monocytes. Infect lmmun 65( 6):2272- 7. 
Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K (1982). 
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. 
Cancer Res 42(4):1530-6. 
Tsukita S, Oishi K, Sato N, Sagara J, Kawai A (1994). ERM family members as 
molecular linkers between the cell surface glycoprotein CD44 and actin-based 
cytoskeletons. J Cell Biol 126(2):391-401. 
144 
Tsukita S, Yonemura S (1997a). ERM proteins: head-to-tail regulation of actin-plasma 
membrane interaction. Trends Biochem Sci 22(2):53-8. 
Tsukita S, Yonemura S (1997b). ERM (ezrin/radixin/moesin) family: from cytoskeleton 
to signal transduction. Curr Opin Cell Biol 9(1):70-5. 
Tsukita S, Yonemura S ( 1999). Cortical actin organization: lessons from ERM 
(ezrin/radixin/moesin) proteins. J Biol Chem 274(49):34507-10. 
Turunen 0, Wahlstrom T, Vaheri A (1994). Ezrin has a COOR-terminal actin-binding 
site that is conserved in the ezrin protein family. J Cell Biol 126(6):1445-53. 
Ulevitch RJ, Tobias PS (1995). Receptor-dependent mechanisms of cell stimulation by 
bacterial endotoxin. Annu Rev Immunol 13(437-57. 
Van Amersfoort ES, Van Berkel TJ, Kuiper J (2003). Receptors, mediators, and 
mechanisms involved in bacterial sepsis and septic shock. Clin Microbial Rev 16(3):379-
414. 
van der Poll T, Lowry SF (1995). Tumor necrosis factor in sepsis: mediator of multiple 
organ failure or essential part of host defense? Shock 3(1):1-12. 
van Furth R, Cohn ZA (1968). The origin and kinetics of mononuclear phagocytes. J Exp 
Med 128(3):415-35. 
van Furth R, Diesselhoff-Den Dulk MM (1970). The kinetics ofpromonocytes and 
monocytes in the bone marrow. J Exp Med 132(4):813-28. 
145 
van Furth R, Cohn ZA, Hirsch JG, Humphrey JH, Spector WG, Langevoort HL (1972). 
The mononuclear phagocyte system: a new classification of macrophages, monocytes, 
and their precursor cells. Bull World Health Organ 46(6):845-52. 
Van Furth R, Diesselhoff-den Dulk MC, Mattie H (1973). Quantitative study on the 
production and kinetics of mononuclear phagocytes during an acute inflammatory 
reaction. J Exp Med 138(6): 1314-30. 
van Furth R, Diesselhoff-den Dulk MM, Raebum JA, van Zwet TL, Crofton Ra, Bluss 
van Alblas A (1980). Characteristics, origin and kinetics of human and murine 
mononuclear phagocytes. In: Mononuclear phagocytes : functional aspects. R van Furth 
editor. New York: Kluwer Academic Publishers, pp. 279-298. 
van Furth R, Sluiter W (1986). Distribution of blood monocytes between a marginating 
and a circulating pool. J Exp Med 163(2):474-9. 
van Furth R ( 1988). Phagocytic cells: development and distribution of mononuclear 
phagocytes in normal steady state and inflammation. In: Inflammation : basic principles 
and clinical correlates. JI Gallin, IM Goldstein and R Snyderman editors. New York: 
Raven Press, pp. 281-296. 
van Furth R (1989). Origin and turnover of monocytes and macrophages. Curr Top 
Pathol 79(125-50. 
Vanden Berghe W, Plaisance S, Boone E, De Bosscher K, Schmitz ML, Fiers W, 
Haegeman G (1998). p38 and extracellular signal-regulated kinase mitogen-activated 
protein kinase pathways are required for nuclear factor-kappaB p65 transactivation 
mediated by tumor necrosis factor. J Biol Chem 273(6):3285-90. 
146 
Vijay-Kumar S, Bugg CE, Wilkinson KD, Vierstra RD, Hatfield PM, Cook WJ (1987). 
Comparison of the three-dimensional structures of human, yeast , and oat ubiquitin. J Biol 
Chem 262(13):6396-9. 
Visintin A, Mazzoni A, Spitzer JA, Segal DM (2001 ). Secreted MD-2 is a large 
polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like 
receptor 4. Proc Natl Acad Sci US A 98(21):12156-61. 
Wajant H, Grell M, Scheurich P (1999). TNF receptor associated factors in cytokine 
signaling. Cy tokine Growth Factor Rev 10(1):15-26 . 
Wang D, Baldwin AS, Jr. (1998). Activation of nuclear factor-kappaB-dependent 
transcription by tumor necrosis factor-alpha is mediated through phosphorylation of 
ReWp65 on serine 529. J Biol Chem 273(45):29411-6. 
Weinstein SL, Sanghera JS, Lemke K, DeFranco AL, Pelech SL (1992). Bacterial 
lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated 
protein kinases in macrophages. J Biol Chem 267(21):14955-62. 
Whitelaw DM (1966). The intravascular lifespan ofmonocytes. Blood 28(3):455-64. 
Whitmarsh AJ, Cavanagh J, Toumier C, Yasuda J, Davis RJ (1998). A mammalian 
scaffold complex that selectively mediates MAP kinase activation. Science 
281(5383): 1671-4. 
Wilkinson MG, Millar JBA (1998). SAPKs and transcription factors do the 
nucleocytoplasmic tango. Genes Dev. 12(10):1391-1397. 
147 
Wilson T, Treisman R (1988). Removal ofpoly(A) and consequent degradation of c-fos 
mRNA facilitated by 3' AU-rich sequences. Nature 336(6197):396-9. 
Wong ML , O'Kirwan F, Khan N, Hannestad J, Wu KH, ElashoffD , Lawson G, Gold 
PW, McCann SM, Licinio J (2003). Identification, characterization , and gene expression 
profiling of endotoxin-induced myocarditis. Proc Natl Acad Sci US A 100(24):14241-6. 
Wright SD, Jong MT (1986). Adhesion-promoting receptors on human macrophages 
recognize Escherichia coli by binding to lipopolysaccharide. J Exp Med 164(6):1876-88. 
Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD (1988). 
Complement receptor type three ( CD 11 b/CD 18) of human polymorphonuclear 
leukocytes recognizes fibrinogen. Proc Natl Acad Sci US A 85(20):7734-8. 
Wright SD, Levin SM, Jong MT, Chad Z, Kabbash LG (1989). CR3 (CDl lb/CD18) 
expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for 
bacterial lipopolysaccharide. J Exp Med 169(1):175-83. 
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990). CD14 , a receptor 
for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 
249( 497 5): 1431-3. 
Wright SD (1991). Multiple receptors for endotoxin. Curr Opin Immunol 3(1):83-90. 
Wurfel MM, Monks BG, Ingalls RR, Dedrick RL, Delude R, Zhou D, Lamping N, 
Schumann RR , Thieringer R, Fenton MJ , Wright SD, Golenbock D (1997). Targeted 
deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound 
suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J Exp 
Med 186(12):2051-6. 
148 
Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, 
Israel A (1998). Complementation cloning ofNEMO, a component of the IkappaB kinase 
complex essential for NF-kappaB activation. Cell 93(7): 1231-40. 
Yamin TT, Miller DK (1997). The interleukin-I receptor-associated kinase is degraded 
by proteasomes following its phosphorylation. J Biol Chem 272(34 ):21540- 7. 
Yang F, Tang E, Guan K, Wang CY (2003). IKK beta plays an essential role in the 
phosphoiylation ofRelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 
170(11):5630-5. 
Yang H, Young DW, Gusovsky F, Chow JC (2000). Cellular events mediated by 
lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of 
mitogen-activated protein kinases and Elk-I. J Biol Chem 275(27):20861-6. 
Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, 
Gurney AL, Godowski PJ (1998). Toll-like receptor-2 mediates lipopolysaccharide-
induced cellular signalling. Nature 395(6699):284-8. 
Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S (1998). 
Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in 
the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 
140(4):885-95. 
Yonemura S, Tsukita S (1999) . Direct involvement of ezrin/radixin/moesin (ERM)-
binding membrane proteins in the organization of microvilli in collaboration with 
activated ERM proteins. J Cell Biol 145(7):1497-509. 
149 
Yoza BK, Hu N, McCall CE (1996). Protein-tyrosine kinase activation is required for 
lipopolysaccharide induction of interleukin 1 beta and NFkappaB activation , but not 
NFkappaB nuclear translocation. J Biol Chem 271(31):18306-9. 
Yuasa T, Ohno S, Kehrl JH, Kyriakis JM (1998). Tumor Necrosis Factor Signaling to 
Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38. 
GERMINAL CENTER KINASE COUPLES TRAF2 TO MITOGEN-ACTIVATED 
PROTEIN KINASE/ERK KINASE KINASE 1 AND SAPK WHILE RECEPTOR 
INTERACTING PROTEIN ASSOCIATES WITH A MITOGEN-ACTIV ATED 
PROTEIN KINASE KINASE KINASE UPSTREAM OF MKK6 AND p38. J. Biol. 
Chem. 273(35):22681-22692. 
Zganiacz A, Santosuosso M, Wang J, Yang T, Chen L, Anzulovic M, Alexander S, 
Gicquel B, Wan Y, Bramson J, Inman M, Xing Z (2004). TNF-alpha is a critical negative 
regulator of type 1 immune activation during intracellular bacterial infection. J Clin 
Invest 113(3):401-13. 
Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, 
Muzio M, Arditi M ( 1999). Bacterial lipopolysaccharide activates nuclear factor-kappaB 
through interleukin- I signaling mediators in cultured human dermal endothelial cells and 
mononuclear phagocytes. J Biol Chem 274(12):7611-4. 
Zhao L, Ohtaki Y, Yamaguchi K, Matsushita M, Fujita T, Yokochi T, Takada H, Endo Y 
(2002). LPS-induced platelet response and rapid shock in mice: contribution of O-antigen 
region of LPS and involvement of the lectin pathway of the complement system. Blood 
100(9):3233-9. 
150 
Zhong H, Su Yang H , Erdjument-Bromage H, Tempst P, Ghosh S (1997). The 
transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc 
subunit through a cyclic AMP-independent mechanism. Cel/ 89(3) :413-24. 
151 
